<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="pmc-domain-id">3416</journal-id><journal-id journal-id-type="pmc-domain">molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12029527</article-id><article-id pub-id-type="pmcid-ver">PMC12029527.1</article-id><article-id pub-id-type="pmcaid">12029527</article-id><article-id pub-id-type="pmcaiid">12029527</article-id><article-id pub-id-type="pmid">40333661</article-id><article-id pub-id-type="doi">10.3390/molecules30081676</article-id><article-id pub-id-type="publisher-id">molecules-30-01676</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Flavonoids and Furanocoumarins Involved in Drug Interactions</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4577-4988</contrib-id><name name-style="western"><surname>Berteina-Raboin</surname><given-names initials="S">Sabine</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Grant</surname><given-names initials="G">George</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-30-01676">Institut de Chimie Organique et Analytique (ICOA), Universit&#233; d&#8217;Orl&#233;ans UMR-CNRS 7311, BP 6759, Rue de Chartres, CEDEX 2, 45067 Orl&#233;ans, France; <email>sabine.berteina-raboin@univ-orleans.fr</email>; Tel.: +33-238-494-856</aff><pub-date pub-type="epub"><day>09</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>30</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">487323</issue-id><elocation-id>1676</elocation-id><history><date date-type="received"><day>16</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>01</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>26</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-08 13:25:35.437"><day>08</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the author.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="molecules-30-01676.pdf"/><abstract><p>Drug interactions can have significant consequences for public health, especially given the growing importance of readily available dietary supplements. The same applies to the consumption of fruit and fruit juices, which are often praised for their health benefits, but which can generate drug interactions. These are well known and documented in the case of grapefruit, which should not be taken with certain medications. Grapefruit contains flavonoids and furanocoumarins, which are responsible for various interactions with the cytochrome P450 enzyme system. However, for young children and the elderly, fruit juices are often used to facilitate treatment. This review examines commonly used fruit juices, particularly from citrus, apple, and red fruits, and discusses potential interactions, disadvantages, and advantages, as well as the chemical structures involved in interactions with cytochromes P-450, P-glycoprotein, and organic anion transporter polypeptide (OATP), responsible for sometimes dangerous changes in bioavailability or potential accumulation of drugs in the body.</p></abstract><kwd-group><kwd>drug interactions</kwd><kwd>furanocoumarins</kwd><kwd>anthocyanins</kwd><kwd>flavonoids</kwd><kwd>coumarins</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-30-01676"><title>1. Introduction</title><p>For the past 30&#8211;40 years, grapefruit and the compounds it contains (flavonoids, and especially furanocoumarins) have been studied for their interactions with certain drugs [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>]. The interaction is not with the drug&#8217;s active ingredient, but with the biological processes involved in its metabolism [<xref rid="B2-molecules-30-01676" ref-type="bibr">2</xref>]. Indeed, any plant substance taken concomitantly with a drug is likely to interact with it if the mechanisms involved in digestion and metabolism involve the same types of receptors [<xref rid="B2-molecules-30-01676" ref-type="bibr">2</xref>,<xref rid="B3-molecules-30-01676" ref-type="bibr">3</xref>]. The danger lies in the potential under- or overdosing of the drug, depending on the interaction, and the appearance of clinical consequences that can be serious [<xref rid="B3-molecules-30-01676" ref-type="bibr">3</xref>,<xref rid="B4-molecules-30-01676" ref-type="bibr">4</xref>,<xref rid="B5-molecules-30-01676" ref-type="bibr">5</xref>], for example, the loss of therapeutic effect or the appearance of side effects. Furanocoumarins inhibit enzymes, which are thus neutralized and can no longer play their metabolic roles in the walls of the liver and intestine. While grapefruit is often implicated in scientific studies of drug interactions, these compounds are also found in other citrus fruits and vegetables. Nevertheless, grapefruit remains highly prized for other interesting effects, such as its contents of vitamin C, the antioxidant lycopene, beta-carotene, and others [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>]. In 1989, the first scientific study showed its interaction with the metabolism of felodipine [<xref rid="B2-molecules-30-01676" ref-type="bibr">2</xref>]. It should be noted that the compounds that appear to be responsible for sometimes serious clinical consequences [<xref rid="B3-molecules-30-01676" ref-type="bibr">3</xref>] are present in much greater quantities in the white part of the fleshy grapefruit skin than in the juice. However, because the juice industry squeezes the fruit with the skin still attached, commercial fruit juices contain much higher levels of furanocoumarins than traditionally squeezed fresh fruit juices. The impact of consuming this fruit in association with certain drugs is therefore more or less significant, and difficult to quantify in daily consumption. It has also been shown that interactions are not only dose-dependent, but also person-dependent, and that it is extremely difficult to measure the potential impact of grapefruit consumption on patients suffering from certain pathologies that are more or less sensitive to these interactions [<xref rid="B4-molecules-30-01676" ref-type="bibr">4</xref>]. Moreover, the presence or absence of grapefruit extracts is not always mentioned, making it difficult to avoid the risk of interactions [<xref rid="B5-molecules-30-01676" ref-type="bibr">5</xref>]. These interactions arise from drug metabolism by cytochromes P450 (CYP). Cytochromes P450 represent a large family of hemoprotein-type enzymes. They share many common features, but are distinguished by their apoproteins [<xref rid="B6-molecules-30-01676" ref-type="bibr">6</xref>,<xref rid="B7-molecules-30-01676" ref-type="bibr">7</xref>].</p><p>Cytochromes P450 (CYPs) are divided into two major classes: the class of interest, involved in the metabolism of xenobiotics, and the class involved in the synthesis of various endogenous substances [<xref rid="B6-molecules-30-01676" ref-type="bibr">6</xref>,<xref rid="B7-molecules-30-01676" ref-type="bibr">7</xref>,<xref rid="B8-molecules-30-01676" ref-type="bibr">8</xref>]. There are several CYPs, including six main types involved in oxidative drug metabolism, including CYP3A4, CYP2D6, CYP1A2, CYP2C8, CYP2C9, and CYP2C19 [<xref rid="B7-molecules-30-01676" ref-type="bibr">7</xref>,<xref rid="B9-molecules-30-01676" ref-type="bibr">9</xref>], but CYP3A is the main enzyme present in the liver and the most involved in drug metabolism. Some CYPs are also present in other organs, notably the intestine. Metabolism may therefore begin in the intestinal walls [<xref rid="B2-molecules-30-01676" ref-type="bibr">2</xref>,<xref rid="B10-molecules-30-01676" ref-type="bibr">10</xref>,<xref rid="B11-molecules-30-01676" ref-type="bibr">11</xref>] before even reaching the liver, depending on how rapidly a given drug is absorbed. Drugs and their metabolites enter the various walls via membrane transporters. Compounds such as furanocoumarins and flavonoids inhibit these actions, thereby altering the bioavailability of orally administered drugs. This leads to potentially dangerous drug accumulation [<xref rid="B12-molecules-30-01676" ref-type="bibr">12</xref>,<xref rid="B13-molecules-30-01676" ref-type="bibr">13</xref>]. Of course, these deleterious interactions only apply to drugs administered via the enteral route, which is the most common method of administration.</p><p>This interaction has been shown to occur mainly in metabolism by cytochromes P450 3A4 (CYP3A4). CYP3As are particularly important, as they are involved in a large number of metabolic processes. This enzymatic inhibition is linked to the presence, among others, of bergamottin and 6&#8242;,7&#8242;-dihydroxybergamottine, furanocoumarins present in significant quantities in grapefruit and listed as irreversible CYP3A4 inhibitors [<xref rid="B3-molecules-30-01676" ref-type="bibr">3</xref>,<xref rid="B11-molecules-30-01676" ref-type="bibr">11</xref>,<xref rid="B14-molecules-30-01676" ref-type="bibr">14</xref>,<xref rid="B15-molecules-30-01676" ref-type="bibr">15</xref>]. Mention should also be made of flavonoids, the most important of which in grapefruit is naringenin (<xref rid="molecules-30-01676-f001" ref-type="fig">Figure 1</xref>). Hepatic inhibition is also possible with high grapefruit consumption [<xref rid="B16-molecules-30-01676" ref-type="bibr">16</xref>]. CYP3A4 inhibition persists for several days [<xref rid="B17-molecules-30-01676" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-01676" ref-type="bibr">18</xref>,<xref rid="B19-molecules-30-01676" ref-type="bibr">19</xref>] and is dependent on furanocoumarin content. However, compositions are known to depend on many factors, from the terroir in which the fruit is grown, through storage conditions, to ripening and mode of consumption (fresh, pasteurized), meaning that many parameters need to be taken into account in order to explain the variable degrees of CYP3A4 inhibition reported [<xref rid="B20-molecules-30-01676" ref-type="bibr">20</xref>].</p><p>The action of flavonoids, in particular naringin, on membrane transporters inhibits organic anion-transporting polypeptides (OATPs) [<xref rid="B21-molecules-30-01676" ref-type="bibr">21</xref>]. This results in a transient decrease in the bioavailability of certain drugs [<xref rid="B22-molecules-30-01676" ref-type="bibr">22</xref>,<xref rid="B23-molecules-30-01676" ref-type="bibr">23</xref>,<xref rid="B24-molecules-30-01676" ref-type="bibr">24</xref>,<xref rid="B25-molecules-30-01676" ref-type="bibr">25</xref>]. A number of mechanisms favoring bioavailability [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>] have also been identified via the inhibitory activities of furanocoumarins and flavonoids on P-glycoprotein (P-gp) [<xref rid="B26-molecules-30-01676" ref-type="bibr">26</xref>]. Interactions have been demonstrated with other fruit juices, notably orange, bitter orange (Seville orange), bergamot, lime, tangelo, mandarin, certain red fruit, grape, and apple juices. To a lesser extent, these juices also inhibit CYP3A4 [<xref rid="B27-molecules-30-01676" ref-type="bibr">27</xref>]. Similarly, at the OATP level, apple juice and orange juice could also increase the absorption of certain drugs [<xref rid="B25-molecules-30-01676" ref-type="bibr">25</xref>], as they also contain flavonoids. These flavonoids could prove very useful in limiting the doses of drugs to be used, if it were possible to increase their bioavailability on demand. In this review, we will attempt to take stock of the chemical structures responsible for these inhibitions, in order to consider modifications that could be envisaged to reduce or increase their impacts.</p></sec><sec sec-type="results" id="sec2-molecules-30-01676"><title>2. Results and Discussion</title><p>There is extensive literature on the interactions between grapefruit juice and various drugs [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>], including anti-cancer agents, anti-infectives, anti-lipemic agents, cardiovascular agents, CNS agents, gastrointestinal and urinary tract agents, etc. Grapefruit juice interferes with a large number of drugs; however, it is difficult to pinpoint the exact impacts of the compounds contained, so, as a precaution, it is recommended not to consume grapefruit juice when taking certain drugs, but what about other foods? D.G. Bailey et al. [<xref rid="B28-molecules-30-01676" ref-type="bibr">28</xref>] showed that naringin was a major and selective clinical inhibitor of organic anion transporter polypeptide 1A2 (OATP1A2) in grapefruit juice. As mentioned in the introduction, this flavonoid has the opposite effect of furanocoumarins, helping to reduce drug absorption, particularly of fexofenadine, analyzed in this study, via grapefruit juice&#8217;s inhibition of the activity of an OATP family protein transporter. The balance between the inverse actions of furanocoumarins and flavonoids, therefore, makes it difficult to anticipate the bioavailability of drugs when consuming grapefruit juice.</p><p>Moreover, according to the same authors, orange and apple juices (1200 mL) also reduced absorption. Furanocoumarins and flavonoids reduced fexofenadine absorption by 28% and 23%, respectively, in these juices. It is not only fruit juices that are responsible for these metabolic problems. Other plant families, including those of certain vegetables, can also generate this type of interaction, even though cold-pressed juices are recommended for the benefits of their vitamin contents in cancer treatment. What about their impacts? In another example, pepper and its component piperine are thought to increase the bioavailability of certain drugs [<xref rid="B29-molecules-30-01676" ref-type="bibr">29</xref>]. The same applies to turmeric, which is often sold with added piperine and taken as a dietary supplement for its anti-inflammatory action. The mechanisms of these effects are not fully defined, but it is thought that their effect on absorption is due in part to their inhibition of gastric emptying. An update on the various juices commonly consumed that may be involved in these drug interactions is listed here, together with the molecules that may be responsible for their effects. Only fruit types that have been studied in humans are mentioned here.</p><p>Coumarins represent an important group of phenolic compounds found in a wide variety of plants [<xref rid="B30-molecules-30-01676" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-01676" ref-type="bibr">31</xref>], listed and described in over 150 plant species [<xref rid="B31-molecules-30-01676" ref-type="bibr">31</xref>]. All coumarin classes have a central structure composed of a benzo-&#945;-pyrone, to which a furan ring can be attached, to yield furanocoumarins or a pyran ring that generate pyranocoumarins. Depending on the positions of these additional rings on the aromatic ring in positions 6, 7 or 7, 8, linear or angular derivatives are obtained. Of the structures to which phenylcoumarins can be added [<xref rid="B30-molecules-30-01676" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-01676" ref-type="bibr">31</xref>,<xref rid="B32-molecules-30-01676" ref-type="bibr">32</xref>,<xref rid="B33-molecules-30-01676" ref-type="bibr">33</xref>] (<xref rid="molecules-30-01676-f002" ref-type="fig">Figure 2</xref>), furanocoumarins, which are of interest to us here, have been referenced in several families [<xref rid="B34-molecules-30-01676" ref-type="bibr">34</xref>], and are mainly found in the <italic toggle="yes">Apiaceae</italic> (parsnip, parsley, celery), <italic toggle="yes">Fabaceae</italic> (coronilla), <italic toggle="yes">Moraceae</italic> (fig), and, of course, <italic toggle="yes">Rutaceae</italic> (bergamot, citrus) families [<xref rid="B30-molecules-30-01676" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-01676" ref-type="bibr">31</xref>,<xref rid="B33-molecules-30-01676" ref-type="bibr">33</xref>,<xref rid="B35-molecules-30-01676" ref-type="bibr">35</xref>,<xref rid="B36-molecules-30-01676" ref-type="bibr">36</xref>,<xref rid="B37-molecules-30-01676" ref-type="bibr">37</xref>]. Furanocoumarins present in these plant families include psoralen, xanthotoxin, bergapten, angelicin, pimpinellin, sphondin, and isobergapten [<xref rid="B38-molecules-30-01676" ref-type="bibr">38</xref>]. It is important to note, however, that the highest concentrations have been reported [<xref rid="B39-molecules-30-01676" ref-type="bibr">39</xref>,<xref rid="B40-molecules-30-01676" ref-type="bibr">40</xref>,<xref rid="B41-molecules-30-01676" ref-type="bibr">41</xref>] in various <italic toggle="yes">Apiaceae</italic> species, such as parsnip (145 &#956;g&#183;g<sup>&#8722;1</sup> FW) or parsley (112 &#956;g&#183;g<sup>&#8722;1</sup> FW), where they occur in much higher concentrations compared with that in grapefruit juice (<italic toggle="yes">Rutaceae</italic>), the most targeted source of drug interactions, wherein the reported furanocoumarin concentration would only be of the order of 6 &#956;g&#183;g<sup>&#8722;1</sup> FW [<xref rid="B36-molecules-30-01676" ref-type="bibr">36</xref>,<xref rid="B40-molecules-30-01676" ref-type="bibr">40</xref>,<xref rid="B42-molecules-30-01676" ref-type="bibr">42</xref>], which is still much lower than that of some <italic toggle="yes">Apiaceae</italic> members.</p><sec id="sec2dot1-molecules-30-01676"><title>2.1. Grapefruit and the General Citrus Family</title><p>D. Black et al. [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>] published an excellent review of drug interactions with grapefruit compounds. Mechanisms of action are discussed for a large number of drug classes. Here, we have mentioned potential pharmacokinetic and pharmacodynamic interactions, focusing mainly on the structures of the molecules involved. For compounds present in grapefruit (<italic toggle="yes">Citrus &#215; paradise</italic>) and all citrus fruits, the biosynthetic pathway of target furanocoumarins starts with phenylalanine to generate umbelliferone or 7-hydroxy-coumarin. Depending on the enzyme, this then leads to linear or angular furanocoumarins. The proportion and presence of this or that enzyme in different citrus fruits generates one or the other, or both, which explains the modulation of the impacts on interactions depending on the citrus fruit studied (<xref rid="molecules-30-01676-f003" ref-type="fig">Figure 3</xref>) [<xref rid="B43-molecules-30-01676" ref-type="bibr">43</xref>,<xref rid="B44-molecules-30-01676" ref-type="bibr">44</xref>].</p><p>The phenolic derivatives found in citrus fruit are derived from caffeic acid, i.e., 3,4-dihydroxycinnamic acid (<xref rid="molecules-30-01676-f004" ref-type="fig">Figure 4</xref>).</p><p>Flavonoids include rutin, a glycosylated derivative of quercetin. It is an antioxidant found in many plants. Narutin is a derivative of (S)-naringenin, which also has antioxidant and anti-inflammatory properties. Naringin, also derived from (S)-naringenin, has antineoplastic and anti-inflammatory properties [<xref rid="B45-molecules-30-01676" ref-type="bibr">45</xref>,<xref rid="B46-molecules-30-01676" ref-type="bibr">46</xref>]. Hesperidin is a glycosidic derivative of hesperetin (<xref rid="molecules-30-01676-f005" ref-type="fig">Figure 5</xref>). All these derivatives of furanocoumarins, phenolic acids, and flavonoids, as well as flavonoid aglycones, are present in different citrus fruits in varying doses, and some compounds are even absent [<xref rid="B47-molecules-30-01676" ref-type="bibr">47</xref>]. This probably explains the varying characteristics and interactions of these different citrus fruits.</p><sec id="sec2dot1dot1-molecules-30-01676"><title>2.1.1. Orange</title><p>As for orange juice (<italic toggle="yes">Valencia</italic>), which is widely consumed, it seems that it can considerably reduce the bioavailability of certain drugs [<xref rid="B1-molecules-30-01676" ref-type="bibr">1</xref>,<xref rid="B48-molecules-30-01676" ref-type="bibr">48</xref>]. This interaction, as with many citrus fruits, could be due in part to modulation of intestinal wall transporters, but also to the acidity of the juices, which could ionize the active molecules, limiting their penetration capacity, as absorbable forms are often non-ionized. In addition to those mentioned above, among the molecules that inhibit OATP2B1 [<xref rid="B21-molecules-30-01676" ref-type="bibr">21</xref>] and, therefore, absorption transporters, is hesperidin [<xref rid="B49-molecules-30-01676" ref-type="bibr">49</xref>]. Hesperidin has a chemical structure very similar to that of naringin, but hesperidin does not produce complete inhibition of OATP1A2-mediated transport activity compared with naringin [<xref rid="B28-molecules-30-01676" ref-type="bibr">28</xref>]. Seville orange juice (<italic toggle="yes">Citrus aurantium</italic>) may interact by inactivating intestinal CYP3A4, but does not alter P-gp concentration in enterocytes [<xref rid="B50-molecules-30-01676" ref-type="bibr">50</xref>]. Depending on the citrus fruit, flavone glycoside composition differs. B.J. Gurley et al. [<xref rid="B51-molecules-30-01676" ref-type="bibr">51</xref>] also studied the synephrine or octopamine content of Seville orange to assess its potential cardiovascular effects in humans (<xref rid="molecules-30-01676-f006" ref-type="fig">Figure 6</xref>).</p><p>M.H. Jin et al. [<xref rid="B47-molecules-30-01676" ref-type="bibr">47</xref>] quantified constituent levels to measure its effects on systolic blood pressure and heart rate. They were able to show, in healthy volunteers, that no significant cardiovascular effects were observed, despite the presence of these compounds (<xref rid="molecules-30-01676-f006" ref-type="fig">Figure 6</xref>). Orange peel contains <italic toggle="yes">p</italic>-coumaric acid and ferulic acid (<xref rid="molecules-30-01676-f004" ref-type="fig">Figure 4</xref>), while the other two phenolic acids are absent. Flavonoid glycosides include narirutin and hesperidin (<xref rid="molecules-30-01676-f004" ref-type="fig">Figure 4</xref>), but not furanocoumarin. A notable variant, however, is Seville orange (bitter orange), in which all four phenolic acids are present, as well as narirutin and naringin, but not hesperidin, while one furanocoumarin (bergapten) is present (<xref rid="molecules-30-01676-f003" ref-type="fig">Figure 3</xref>).</p></sec><sec id="sec2dot1dot2-molecules-30-01676"><title>2.1.2. Lime</title><p>The interaction between lime juice (<italic toggle="yes">Citrus aurantiifolia</italic> and <italic toggle="yes">Citrus latifolia</italic>) and drugs is strongly linked to flavonoid compounds, but also to its high vitamin C content. Vitamin C&#8217;s antioxidant properties may play a role in the efficacy of certain drugs, such as antimalarials [<xref rid="B52-molecules-30-01676" ref-type="bibr">52</xref>]. The health effects of vitamin C are manifold, including the inhibition of CYP3A4 [<xref rid="B53-molecules-30-01676" ref-type="bibr">53</xref>] and CYP2C9, with concomitant action on OATP2B1, since the same flavonoids and polyphenols are found in grapefruit. Caffeic acid, p-coumaric acid, ferulic acid, rutin, narirutin, naringin, naringenin (flavonoid aglycone), hesperetin (flavonoid aglycone), bergapten, and bergamottin are found in citrus peel [<xref rid="B47-molecules-30-01676" ref-type="bibr">47</xref>], and are, therefore, present in commercial fruit juices. L. Mondello et al. [<xref rid="B54-molecules-30-01676" ref-type="bibr">54</xref>] demonstrated the presence of the main constituents in this juice by HPLC determination with UV detection. Their study was carried out on fruit from Calabria, Italy, and showed a high proportion of the flavonoids hesperidin and eriocitrin, as well as, to a lesser extent, isonaringenin, vicenin, and lucenin, in addition to lower proportions of coumarins (5-geranyloxy-7-methoxy-coumarin) and psoralens (bergamottin and oxypeucedanin hydrate) (<xref rid="molecules-30-01676-f007" ref-type="fig">Figure 7</xref>).</p></sec><sec id="sec2dot1dot3-molecules-30-01676"><title>2.1.3. Pomelo</title><p>Pomelo (<italic toggle="yes">Citrus grandis</italic> L. <italic toggle="yes">Osbeck</italic> or <italic toggle="yes">Citrus maxima</italic>) inhibits CYP2C9, CYP3A, and/or P-gp activity in the intestine. Drugs metabolized by CYP3A4 should be more bioavailable, but this effect is reduced by the action of pomelo juice on absorption transporters. Other physicochemical interactions may also be due to other components of pomelo juice [<xref rid="B55-molecules-30-01676" ref-type="bibr">55</xref>]. In addition to being rich in vitamin C [<xref rid="B56-molecules-30-01676" ref-type="bibr">56</xref>] <italic toggle="yes">Citrus grandis</italic>, like other citrus fruits, contains a variety of active compounds that are highly beneficial to health, but may also give rise to drug interactions [<xref rid="B57-molecules-30-01676" ref-type="bibr">57</xref>]. These include rutin, meranzin hydrate, apigenin, tangeretin, nobiletin, and taddanone, as well as epicatechin [<xref rid="B58-molecules-30-01676" ref-type="bibr">58</xref>], which is found in the peel of the pomelo, and also in green teas, where it does not appear to pose problems (<xref rid="molecules-30-01676-f005" ref-type="fig">Figure 5</xref> and <xref rid="molecules-30-01676-f008" ref-type="fig">Figure 8</xref>). The pulp and juice of <italic toggle="yes">Citrus grandis</italic> L. contain phenolic acids such as caffeic acid, <italic toggle="yes">p</italic>-coumaric acid, and ferulic acid (<xref rid="molecules-30-01676-f004" ref-type="fig">Figure 4</xref>), as well as naringin, 5-geranyl-7-methoxycoumarin, and hesperidin, which are also present in other citrus fruits.</p></sec></sec><sec id="sec2dot2-molecules-30-01676"><title>2.2. Fig</title><p>The fig tree (<italic toggle="yes">ficus carica</italic> L.) is a fruit tree in the <italic toggle="yes">Moraceae</italic> family. Ficus species contain alkaloids, terpenoids, and phenols. Alkaloids are of the indolizidine, chlorophenanthroindolizidine, septicine, and furoquinolines type; their role in the plant is to provide defensive properties [<xref rid="B59-molecules-30-01676" ref-type="bibr">59</xref>,<xref rid="B60-molecules-30-01676" ref-type="bibr">60</xref>,<xref rid="B61-molecules-30-01676" ref-type="bibr">61</xref>,<xref rid="B62-molecules-30-01676" ref-type="bibr">62</xref>,<xref rid="B63-molecules-30-01676" ref-type="bibr">63</xref>]. Terpenoids include monoterpenoids, triterpenoids, sesquiterpenoids, steroids, and norisoprenoids, whose properties are somewhat distant from our subject, since they are antibacterial, insecticidal, and antiproliferative [<xref rid="B64-molecules-30-01676" ref-type="bibr">64</xref>,<xref rid="B65-molecules-30-01676" ref-type="bibr">65</xref>,<xref rid="B66-molecules-30-01676" ref-type="bibr">66</xref>,<xref rid="B67-molecules-30-01676" ref-type="bibr">67</xref>]. The phenolic compounds of ficus have been extensively studied and include, in addition to phenolic acids, flavonoids, coumarins, pyranocoumarins, furanocoumarins, and tannins, or phlobatannins. These derivatives have antioxidant, antimycobacterial, or nematicidal properties, which is not surprising given their structures, and they interact most with drugs [<xref rid="B68-molecules-30-01676" ref-type="bibr">68</xref>,<xref rid="B69-molecules-30-01676" ref-type="bibr">69</xref>,<xref rid="B70-molecules-30-01676" ref-type="bibr">70</xref>,<xref rid="B71-molecules-30-01676" ref-type="bibr">71</xref>]. <italic toggle="yes">Ficus carica</italic> L. is also known in traditional medicine for its numerous hepatoprotective, antifungal, anti-inflammatory, and hypoglycemic virtues. It has also been cited as a treatment for diabetes [<xref rid="B72-molecules-30-01676" ref-type="bibr">72</xref>]. S. Igncimuthu et al. [<xref rid="B73-molecules-30-01676" ref-type="bibr">73</xref>] studied the beneficial effect of <italic toggle="yes">ficus carica</italic> leaves on the glucose and lipid levels in type 2 diabetic rats. However, L. Wang et al. [<xref rid="B74-molecules-30-01676" ref-type="bibr">74</xref>] who very recently documented the compounds and metabolites present at different levels of the plant, showed that the leaves contain psoralen and bergapten, in particular. Leaf decoctions could, therefore, be involved in drug interactions, given their composition. Fruits contain glycosylated quercetins and derivatives. Interactions with anticoagulants have also been reported. At the very least, the effect of ficus on glycemia could generate pharmacodynamic interactions, with synergistic and, therefore, additive and cumulative effects with antidiabetic treatments. The main furanocoumarins are, therefore, two linear isomers: psoralen and bergapten [<xref rid="B69-molecules-30-01676" ref-type="bibr">69</xref>,<xref rid="B70-molecules-30-01676" ref-type="bibr">70</xref>,<xref rid="B75-molecules-30-01676" ref-type="bibr">75</xref>]. Another glycosylated compound of psoralen (psoralic acid glucoside) is also present in large quantities. Other linear furanocoumarins include marmesin, xanthotoxol [<xref rid="B76-molecules-30-01676" ref-type="bibr">76</xref>], xanthotoxin, rutaretin [<xref rid="B77-molecules-30-01676" ref-type="bibr">77</xref>], 4&#8242;,5&#8242;-dihydropsoralen, and 5-(1&#8243;,1&#8243;-dimethylallyl)-8-methylpsoralen [<xref rid="B78-molecules-30-01676" ref-type="bibr">78</xref>]. In addition, there are two angular furanocoumarins: angelicin and pimpinellin [<xref rid="B77-molecules-30-01676" ref-type="bibr">77</xref>] (<xref rid="molecules-30-01676-f009" ref-type="fig">Figure 9</xref>). Several of these compounds have been described in other Ficus species.</p><p>In addition to citrus fruits, apples, and figs, which are known for this type of drug interaction, other fruits are beginning to be widely studied, as they are being recommended for their benefits and, therefore, consumed without reservation; however, they may contain the constituents incriminated in citrus fruits.</p></sec><sec id="sec2dot3-molecules-30-01676"><title>2.3. Blackberry</title><p>The blackberry is a fruit belonging to the <italic toggle="yes">Moraceae</italic> family, of which there are many species, but the following three&#8212;<italic toggle="yes">Morus alba</italic>, <italic toggle="yes">Morus nigra</italic>, and <italic toggle="yes">Morus rubra</italic>&#8212;are the most studied for their medicinal properties [<xref rid="B79-molecules-30-01676" ref-type="bibr">79</xref>]. This fruit is reputed to be beneficial in a wide range of pathologies and, therefore, has an extremely broad spectrum of action. Moreover, blackberries are readily available and marketed in a variety of forms. Numerous potential therapeutic applications have been reported, and, in juice form, blackberries are said to help boost immunity [<xref rid="B80-molecules-30-01676" ref-type="bibr">80</xref>], as well as fight inflammation [<xref rid="B81-molecules-30-01676" ref-type="bibr">81</xref>], chronic diseases [<xref rid="B82-molecules-30-01676" ref-type="bibr">82</xref>], and liver problems [<xref rid="B83-molecules-30-01676" ref-type="bibr">83</xref>]. These fruits contain compounds similar to those found in the fruits already mentioned, namely anthocyanins, phloridzin, and quercetin, as well as rutin, resveratrol, and chlorogenic acid (<xref rid="molecules-30-01676-f010" ref-type="fig">Figure 10</xref>). Different pathways leading to anthocyanins or flavonols [<xref rid="B84-molecules-30-01676" ref-type="bibr">84</xref>] synthesize the widely present flavonoids. Blackberry juice has been reported by Y.C. Hou et al. [<xref rid="B85-molecules-30-01676" ref-type="bibr">85</xref>] to inhibit CYP3A1 and OATP-B, as well as modulate CYP or even activate CYP3A1 and p-glycoprotein. They studied the impact on cyclosporine, an immunosuppressive drug used to prevent transplant rejection or treat rheumatoid arthritis [<xref rid="B86-molecules-30-01676" ref-type="bibr">86</xref>]. Cyclosporine involves both CYP3A4 and P-glycoproteins (P-gp) during oral absorption, making it a drug of choice for testing potential interactions [<xref rid="B87-molecules-30-01676" ref-type="bibr">87</xref>]. Rutin, quercetin, resveratrol, and kaempferol (<xref rid="molecules-30-01676-f010" ref-type="fig">Figure 10</xref>) have already been shown to modulate P-gp [<xref rid="B88-molecules-30-01676" ref-type="bibr">88</xref>,<xref rid="B89-molecules-30-01676" ref-type="bibr">89</xref>] and CYP3A4 [<xref rid="B90-molecules-30-01676" ref-type="bibr">90</xref>,<xref rid="B91-molecules-30-01676" ref-type="bibr">91</xref>,<xref rid="B92-molecules-30-01676" ref-type="bibr">92</xref>]. The effects of these compounds on P-gp or CYP3A4 are sometimes inverse, sometimes inhibitory [<xref rid="B93-molecules-30-01676" ref-type="bibr">93</xref>], and sometimes stimulatory [<xref rid="B90-molecules-30-01676" ref-type="bibr">90</xref>], making it difficult to assess their overall effects. Synergistic effects may also be present, depending on the type of juice; however, in vivo, they reduce the oral bioavailability of cyclosporine in rats [<xref rid="B94-molecules-30-01676" ref-type="bibr">94</xref>]. Indeed, YC Hou et al. [<xref rid="B85-molecules-30-01676" ref-type="bibr">85</xref>] studied the effect of blackberry serum on cyclosporine pharmacokinetics in rats, and were able to demonstrate a decrease in cyclosporine absorption through activation of P-gp and CYP3A4. They incriminate quercetin and rutin in these interactions, although they are not present in very large quantities in blackberries, but advise against consumption of these fruits when taking drugs that are substrates of P-gp and/or CYP3A4. However, a study on human volunteers should be carried out to be sure, as we have seen with pomegranate juice that an in vitro interaction has not been confirmed in human clinical trials.</p></sec><sec id="sec2dot4-molecules-30-01676"><title>2.4. Apple</title><p>As mentioned in the introduction, apple juice ingestion has been shown to significantly reduce the absorption of certain drugs, notably fexofenadine, by prolonging the time required to reach peak plasma concentration [<xref rid="B95-molecules-30-01676" ref-type="bibr">95</xref>]. Apple juice (<italic toggle="yes">Malus domestica</italic>, <italic toggle="yes">Rosaceae</italic> family) inhibited organic anion transporter polypeptide 2B1 (OATP2B1) in the intestine in a dose-dependent manner, without the need for repeated apple juice ingestion [<xref rid="B95-molecules-30-01676" ref-type="bibr">95</xref>]. In their study, the authors did not mention the ingredients responsible for the observed effects, but others have shown that the flavonoids present in apple juice in varying quantities are phloridzin, phloretin, hesperidin, and quercetin (<xref rid="molecules-30-01676-f011" ref-type="fig">Figure 11</xref>). While furanocoumarins act primarily on CYPs, apple juice inhibits CYP1A1. Flavonoids act on membrane transporters, inhibiting drug absorption by OATP2B1 [<xref rid="B21-molecules-30-01676" ref-type="bibr">21</xref>]. OATP1 and OATP3 are also inhibited, and the presence of polyphenols is involved [<xref rid="B96-molecules-30-01676" ref-type="bibr">96</xref>,<xref rid="B97-molecules-30-01676" ref-type="bibr">97</xref>]. However, various studies on other drugs not necessarily involving OATP2B1 have also shown interactions, and it appears that a plasma membrane monoamine transporter (PMAT/SLC29A4) may also be involved in these drug interactions at the level of ingestion. Yuasa H et al. showed that phloretin, quercetin, quercetin-3&#223;-d-glucoside, rutin, and phlorizin had inhibitory effects on PMAT [<xref rid="B98-molecules-30-01676" ref-type="bibr">98</xref>]. Apple juice, on the other hand, generally has no modulatory effect on CYP3A [<xref rid="B99-molecules-30-01676" ref-type="bibr">99</xref>].</p></sec><sec id="sec2dot5-molecules-30-01676"><title>2.5. Pomegranate</title><p>Pomegranate (<italic toggle="yes">Punica granatum</italic> L. <italic toggle="yes">Lythraceae</italic> family) contains anthocyanins, which give it its characteristic color, and flavonoids, responsible for the antioxidant activity attributed to this fruit [<xref rid="B100-molecules-30-01676" ref-type="bibr">100</xref>]. Other compounds, present in significant quantities and likely to present drug interactions, are hydroxycinnamic acids (<xref rid="molecules-30-01676-f004" ref-type="fig">Figure 4</xref>). The juice also contains catechins [<xref rid="B101-molecules-30-01676" ref-type="bibr">101</xref>], proanthocyanidins, quercetin, and elagitannins (punicalin and punicalagin, specific to pomegranates, <xref rid="molecules-30-01676-f012" ref-type="fig">Figure 12</xref>) [<xref rid="B102-molecules-30-01676" ref-type="bibr">102</xref>]. The much harder peel contains flavonoids, glycosylated and non-glycosylated flavonols, and glycosylated and non-glycosylated flavones. Pomegranate juice has been shown to inhibit CYP2C9 in vitro, and D.J. Greenblatt et al. [<xref rid="B103-molecules-30-01676" ref-type="bibr">103</xref>] conducted a study on flurbiprofen in human volunteers; however, consuming this juice did not alter clearance of the drug. Similarly, another study on midazolam showed no significant change in the compound&#8217;s pharmacokinetics [<xref rid="B104-molecules-30-01676" ref-type="bibr">104</xref>]. Despite the in vitro results, it appears that concomitant intake of pomegranate juice with the drugs tested does not affect their bioavailability and, therefore, has no in vivo inhibitory action on CYP3A4 [<xref rid="B105-molecules-30-01676" ref-type="bibr">105</xref>]. On the other hand, the presence of polyphenols, and, therefore, antioxidants, effectively limits inflammation and oxidative stress [<xref rid="B106-molecules-30-01676" ref-type="bibr">106</xref>]. To the best of our knowledge, no drug interactions have been demonstrated, and pomegranate is said to have beneficial effects. Unfortunately, this juice is not widely commercially available, unlike traditional juices.</p></sec><sec id="sec2dot6-molecules-30-01676"><title>2.6. Cranberry</title><p>In studies on human volunteers, cranberry juice (<italic toggle="yes">Vaccinium macrocarpon</italic>, <italic toggle="yes">Ericaceae</italic> family) did not alter drug pharmacokinetics. Warfarin, tizanidine, and midazolam were tested, and the CYPs involved were CYP2C9, CYP1A2, and CYP3A4, respectively [<xref rid="B107-molecules-30-01676" ref-type="bibr">107</xref>,<xref rid="B108-molecules-30-01676" ref-type="bibr">108</xref>,<xref rid="B109-molecules-30-01676" ref-type="bibr">109</xref>,<xref rid="B110-molecules-30-01676" ref-type="bibr">110</xref>]. As with pomegranate juice, its use in combination with flurbiprofen did not alter the CYP2C9-mediated clearance of flurbiprofen [<xref rid="B111-molecules-30-01676" ref-type="bibr">111</xref>]. In the various studies, no drug interactions could be measured with cranberry juice, which was even used in combination with the triple antibiotic therapy of omeprazole, amoxicillin, and clarithromycin, although this study showed an improvement in the efficacy of these antibiotics against <italic toggle="yes">H. pylori</italic> bacteria in women [<xref rid="B111-molecules-30-01676" ref-type="bibr">111</xref>]. Among the compounds responsible for these beneficial activities [<xref rid="B112-molecules-30-01676" ref-type="bibr">112</xref>] are flavan-3-ol monomers and dimers; proanthocyanidins; anthocyanins; hydroxycinnamic acids, also found in citrus pulp; and a number of terpenes and flavonols [<xref rid="B113-molecules-30-01676" ref-type="bibr">113</xref>]. As in pomegranate juice, flavan-3-ols of the epicatechin and catechin types, with traces of epigallocatechins and proanthocyanidins, are also present, which could perhaps prevent these drug interactions, since these compounds do not appear to be present in citrus fruits. Similarly, it has not been established with certainty which constituents are responsible for these drug interactions. The potentially interesting molecules present in cranberries are listed in <xref rid="molecules-30-01676-f013" ref-type="fig">Figure 13</xref>. Among the compounds most resistant to juice manufacturing processes such as pasteurization, while remaining sensitive to high temperatures, are flavonols and proanthocyanins, with anthocyanins being rather fragile constituents.</p></sec><sec id="sec2dot7-molecules-30-01676"><title>2.7. Blueberry</title><p>Unlike many of the other fruits discussed herein, blueberry is beneficial in the treatment of certain diseases, and does not act on the same receptors as citrus juices [<xref rid="B114-molecules-30-01676" ref-type="bibr">114</xref>]. In 2012, Greenblatt et al. [<xref rid="B115-molecules-30-01676" ref-type="bibr">115</xref>] studied the potential interactions of blueberry juice with drugs. The anthocyanins and flavonoids present in blueberries have the same beneficial effects as those associated with cranberries [<xref rid="B116-molecules-30-01676" ref-type="bibr">116</xref>,<xref rid="B117-molecules-30-01676" ref-type="bibr">117</xref>] and account for a large proportion of the phenolic compounds present [<xref rid="B118-molecules-30-01676" ref-type="bibr">118</xref>]. There are two main varieties of blueberry, <italic toggle="yes">Vaccinium angustifolium</italic> Aiton and <italic toggle="yes">Vaccinium corymbosum</italic> L., both from the <italic toggle="yes">Ericaceae</italic> family, but with different flavonoid contents [<xref rid="B117-molecules-30-01676" ref-type="bibr">117</xref>]. Until 2012, the date of Greenblatt&#8217;s study [<xref rid="B115-molecules-30-01676" ref-type="bibr">115</xref>], no clinical information was available on possible interactions with medical treatments. The CYP3A and CYP2C9 activities of blueberry juice were therefore assessed in humans, first in vitro with triazolam and buspirone for CYP3A evaluation, as well as with flurbiprofen as the indicator substrate for CYP2C9. Clinical trials were then conducted in volunteers, using buspirone and flurbiprofen as CYP3A and CYP2C9 substrates, respectively. In clinical studies, blueberry juice ingested by patients contained malvidin 3-glucoside and malvidin 3-galactoside (<xref rid="molecules-30-01676-f014" ref-type="fig">Figure 14</xref>), among anthocyanin derivatives present in greater quantities. In vitro, blueberry juice has been shown to inhibit the transformations of triazolam and buspirone, i.e., CYP3A substrates, as well as flurbiprofen; however, in this pharmacokinetic study, none of the clinical trials revealed any adverse effects, but the study was carried out on a very small number of individuals (nine men and three women). Blueberry juice may reduce the symptoms of certain diseases, particularly idiopathic arthritis; reduces levels of interleukin-1 alpha and beta; and increases levels of interleukin-1 receptor antagonists. Pang et al. [<xref rid="B119-molecules-30-01676" ref-type="bibr">119</xref>] demonstrated in 2015 in their study on a larger clinical trial (201 patients with juvenile idiopathic arthritis) that blueberry juice could not only limit inflammation, but, at the same time, reduce the side effects of etanercept, thus improving the treatment of juvenile idiopathic arthritis with etanercept [<xref rid="B119-molecules-30-01676" ref-type="bibr">119</xref>].</p><p>Fruits and their juices have been classified according to their potential drug interactions, starting with the <italic toggle="yes">Rutaceae</italic> family and ending with fruits whose in vivo interaction has not been proven. These fruits can, therefore, be consumed in conjunction with medical treatment without any proven risk of over- or under-dosing. The fruits mentioned in this review are listed in <xref rid="molecules-30-01676-t001" ref-type="table">Table 1</xref>, together with their constituents and the biological interactions that may give rise to drug interactions.</p><p>Given the results of the studies presented here, covering several botanical families, we note that some of them may be involved in drug interactions, as they contain identical constituents (coumarins and furanocoumarins). However, although red fruits are considered analogous, they belong to botanical families that may be different. It seems that the <italic toggle="yes">Ericaceae</italic> or <italic toggle="yes">Lythraceae</italic> families contain additional chemical compounds more likely to have beneficial effects (cranberry; blueberry or pomegranate), and that no drug interactions have been proven for this family.</p></sec></sec><sec sec-type="conclusions" id="sec3-molecules-30-01676"><title>3. Conclusions</title><p>Studies on drug interactions are often carried out on fruit juices, as drugs are frequently taken with fruit juices to mask the taste or the astringency caused by some galenic forms. However, as some drugs are also taken with meals, it would be interesting to study potential interactions with the consumption of certain vegetables, especially if eaten raw. The literature on vegetables is still too sparse. It appears that, while citrus juices undoubtedly interfere with a large proportion of oral medications due to their inhibition of CYP3A4, this is not the case with some red fruits, including pomegranates, which could even have interesting synergistic effects, or reduce certain side effects. The impacts of the type of consumption&#8212;whole fruit or fruit juice&#8212;is important. The use of fresh or processed fruit also plays a role. Industrial fruit juices are made by pressing, and therefore include all constituents of the fruit, particularly in the case of citrus fruits: juice, pulp, and peel. These drug interactions are particularly important for the elderly, who often take several medications, increasing the risk of cross-interactions. Interactions are dose- and person-dependent, making prediction extremely difficult, hence the safety recommendation not to drink grapefruit juice while taking medication. Furthermore, no account is taken of variations in composition depending on where the fruit is grown and how it ripens. It would be interesting to test the various compounds present in these fruits alone or together, in order to envisage a natural constituent of this type that, added to the galenic form of the drugs, could increase their bioavailability or transport. This would make it possible to reduce useful doses and the associated side effects.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was performed using the equipment of Orleans University and Institute of Organic and Analytical Chemistry.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CYP</td><td align="left" valign="middle" rowspan="1" colspan="1">Cytochrome P450</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OATP</td><td align="left" valign="middle" rowspan="1" colspan="1">Organic Anion-transporting Polypeptides</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">P-gp</td><td align="left" valign="middle" rowspan="1" colspan="1">P-glycoprotein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CNS</td><td align="left" valign="middle" rowspan="1" colspan="1">Central Nervous System</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FW</td><td align="left" valign="middle" rowspan="1" colspan="1">Fresh Weight</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HPLC</td><td align="left" valign="middle" rowspan="1" colspan="1">High-performance Liquid Chromatography</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">UV</td><td align="left" valign="middle" rowspan="1" colspan="1">Ultraviolet radiation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMAT</td><td align="left" valign="middle" rowspan="1" colspan="1">Plasma Membrane monoamine Transporter</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SLC29</td><td align="left" valign="middle" rowspan="1" colspan="1">Solute carrier 29 transporters</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-molecules-30-01676"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seden</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dickinson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Khoo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Back</surname><given-names>D.</given-names></name></person-group><article-title>Grapefruit-Drug Interactions</article-title><source>Drugs</source><year>2010</year><volume>70</volume><fpage>2373</fpage><lpage>2407</lpage><pub-id pub-id-type="doi">10.2165/11585250-000000000-00000</pub-id><pub-id pub-id-type="pmid">21142260</pub-id></element-citation></ref><ref id="B2-molecules-30-01676"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Culm-Merdek</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>von Moltke</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Horan</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>R.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Court</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: Comparison with ritonavir</article-title><source>Clin. Pharmacol. Ther.</source><year>2006</year><volume>79</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.clpt.2005.11.009</pub-id><pub-id pub-id-type="pmid">16513448</pub-id></element-citation></ref><ref id="B3-molecules-30-01676"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Dresser</surname><given-names>G.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>J.M.</given-names></name></person-group><article-title>Grapefruit-medication interactions: Forbidden fruit or avoidable consequences?</article-title><source>CMAJ</source><year>2013</year><volume>185</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1503/cmaj.120951</pub-id><pub-id pub-id-type="pmid">23184849</pub-id><pub-id pub-id-type="pmcid">PMC3589309</pub-id></element-citation></ref><ref id="B4-molecules-30-01676"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roulet</surname><given-names>L.</given-names></name><name name-style="western"><surname>Asseray</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mottier</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Chiffoleau</surname><given-names>A.</given-names></name><name name-style="western"><surname>Potel</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lapeyre-Mestre</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ballereau</surname><given-names>F.</given-names></name></person-group><article-title>Grapefruit consumption and food-drug interaction hazard</article-title><source>Therapie</source><year>2011</year><volume>66</volume><fpage>421</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.2515/therapie/2011051</pub-id><pub-id pub-id-type="pmid">22031686</pub-id></element-citation></ref><ref id="B5-molecules-30-01676"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auten</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Beauchamp</surname><given-names>L.N.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hardinger</surname><given-names>K.L.</given-names></name></person-group><article-title>Hidden sources of grapefruit in beverages: Potential interactions with immunosuppressant medications</article-title><source>Hosp. Pharm.</source><year>2013</year><volume>48</volume><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1310/hpj4806-489</pub-id><pub-id pub-id-type="pmid">24421511</pub-id><pub-id pub-id-type="pmcid">PMC3839496</pub-id></element-citation></ref><ref id="B6-molecules-30-01676"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beaune</surname><given-names>P.</given-names></name></person-group><article-title>Human cytochromes P450. Applications in pharmacology</article-title><source>Therapie</source><year>1993</year><volume>48</volume><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">8091338</pub-id></element-citation></ref><ref id="B7-molecules-30-01676"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>A.Y.</given-names></name></person-group><article-title>Inhibition and induction of cytochrome P450 and the clinical implications</article-title><source>Clin. Pharmacokinet.</source><year>1998</year><volume>35</volume><fpage>361</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.2165/00003088-199835050-00003</pub-id><pub-id pub-id-type="pmid">9839089</pub-id></element-citation></ref><ref id="B8-molecules-30-01676"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Stubbins</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Harries</surname><given-names>L.W.</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>C.R.</given-names></name></person-group><article-title>Molecular genetics of the human cytochrome P450 monooxygenase superfamily</article-title><source>Xenobiotica</source><year>1998</year><volume>28</volume><fpage>1129</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1080/004982598238868</pub-id><pub-id pub-id-type="pmid">9890157</pub-id></element-citation></ref><ref id="B9-molecules-30-01676"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rendic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Di Carlo</surname><given-names>F.J.</given-names></name></person-group><article-title>Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors</article-title><source>Drug Metab. Rev.</source><year>1997</year><volume>29</volume><fpage>413</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.3109/03602539709037591</pub-id><pub-id pub-id-type="pmid">9187528</pub-id></element-citation></ref><ref id="B10-molecules-30-01676"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kane</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Lipsky</surname><given-names>J.J.</given-names></name></person-group><article-title>Drug-grapefruit juice interactions</article-title><source>Mayo Clin. Proc.</source><year>2000</year><volume>75</volume><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.4065/75.9.933</pub-id><pub-id pub-id-type="pmid">10994829</pub-id></element-citation></ref><ref id="B11-molecules-30-01676"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lown</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Janardan</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Adair</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Fortlage</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>P.B.</given-names></name></person-group><article-title>Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression</article-title><source>J. Clin. Investig.</source><year>1997</year><volume>99</volume><fpage>2545</fpage><lpage>2553</lpage><pub-id pub-id-type="doi">10.1172/JCI119439</pub-id><pub-id pub-id-type="pmid">9153299</pub-id><pub-id pub-id-type="pmcid">PMC508096</pub-id></element-citation></ref><ref id="B12-molecules-30-01676"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petitet</surname><given-names>F.</given-names></name></person-group><article-title>Interactions pharmacocin&#233;tiques entre pr&#233;parations &#224; base de plantes et m&#233;dicament: Une revue de l&#8217;importance clinique</article-title><source>Phytoth&#233;rapie</source><year>2012</year><volume>10</volume><fpage>170</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/s10298-012-0705-2</pub-id></element-citation></ref><ref id="B13-molecules-30-01676"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirmohamed</surname><given-names>M.</given-names></name></person-group><article-title>Drug&#8211;grapefruit juice interactions: Two mechanisms are clear but individual responses vary</article-title><source>BMJ</source><year>2013</year><volume>346</volume><fpage>f1</fpage><pub-id pub-id-type="doi">10.1136/bmj.f1</pub-id><pub-id pub-id-type="pmid">23297175</pub-id></element-citation></ref><ref id="B14-molecules-30-01676"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>L.Q.</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yamazoe</surname><given-names>Y.</given-names></name></person-group><article-title>Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity</article-title><source>Drug Metab. Dispos.</source><year>2000</year><volume>28</volume><fpage>766</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/S0090-9556(24)15346-9</pub-id><pub-id pub-id-type="pmid">10859150</pub-id></element-citation></ref><ref id="B15-molecules-30-01676"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>L.Q.</given-names></name><name name-style="western"><surname>Yamazoe</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines</article-title><source>Acta Pharmacol. Sin.</source><year>2004</year><volume>25</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">14769198</pub-id></element-citation></ref><ref id="B16-molecules-30-01676"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veronese</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Gillen</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Burke</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Dorval</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Hauck</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Pequignot</surname><given-names>E.</given-names></name><name name-style="western"><surname>Waldman</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>H.E.</given-names></name></person-group><article-title>Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice</article-title><source>J. Clin. Pharmacol.</source><year>2003</year><volume>43</volume><fpage>831</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1177/0091270003256059</pub-id><pub-id pub-id-type="pmid">12953340</pub-id></element-citation></ref><ref id="B17-molecules-30-01676"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>von Moltke</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Weemhoff</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Jen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>LeDuc</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Zinny</surname><given-names>M.A.</given-names></name></person-group><article-title>Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice</article-title><source>Clin. Pharmacol. Ther.</source><year>2003</year><volume>74</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/S0009-9236(03)00118-8</pub-id><pub-id pub-id-type="pmid">12891222</pub-id></element-citation></ref><ref id="B18-molecules-30-01676"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takanaga</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matsuo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Higuchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Urae</surname><given-names>A.</given-names></name><name name-style="western"><surname>Irie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Furuie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matsukuma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects</article-title><source>Clin. Pharmacol. Ther.</source><year>2000</year><volume>67</volume><fpage>201</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1067/mcp.2000.104215</pub-id><pub-id pub-id-type="pmid">10741622</pub-id></element-citation></ref><ref id="B19-molecules-30-01676"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Reg&#229;rdh</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Edgar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Johnsson</surname><given-names>G.</given-names></name></person-group><article-title>Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects</article-title><source>Eur. J. Clin. Pharmacol.</source><year>1995</year><volume>49</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/BF00192360</pub-id><pub-id pub-id-type="pmid">8751023</pub-id></element-citation></ref><ref id="B20-molecules-30-01676"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cancalon</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Haun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Widmer</surname><given-names>W.W.</given-names></name></person-group><article-title>Effect of maturity, processing, and storage on the furanocoumarin composition of grapefruit and grapefruit juice</article-title><source>J. Food Sci.</source><year>2011</year><volume>76</volume><fpage>C543</fpage><lpage>C548</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2011.02147.x</pub-id><pub-id pub-id-type="pmid">22417333</pub-id></element-citation></ref><ref id="B21-molecules-30-01676"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirasaka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shichiri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mori</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nakanishi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tamai</surname><given-names>I.</given-names></name></person-group><article-title>Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions</article-title><source>J. Pharm. Sci.</source><year>2013</year><volume>102</volume><fpage>3418</fpage><lpage>3426</lpage><pub-id pub-id-type="doi">10.1002/jps.23653</pub-id><pub-id pub-id-type="pmid">23794501</pub-id></element-citation></ref><ref id="B22-molecules-30-01676"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dresser</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Leake</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>U.I.</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>R.B.</given-names></name></person-group><article-title>Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine</article-title><source>Clin. Pharmacol. Ther.</source><year>2002</year><volume>71</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1067/mcp.2002.121152</pub-id><pub-id pub-id-type="pmid">11823753</pub-id></element-citation></ref><ref id="B23-molecules-30-01676"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glaeser</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Dresser</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Gregor</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>U.I.</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Jolicoeur</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W.</given-names></name><name name-style="western"><surname>Leake</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Tirona</surname><given-names>R.G.</given-names></name><etal/></person-group><article-title>Intestinal drug transporter expression and the impact of grapefruit juice in humans</article-title><source>Clin. Pharmacol. Ther.</source><year>2007</year><volume>81</volume><fpage>362</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1038/sj.clpt.6100056</pub-id><pub-id pub-id-type="pmid">17215845</pub-id></element-citation></ref><ref id="B24-molecules-30-01676"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dresser</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name></person-group><article-title>Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: Possible role of organic anion transporting polypeptides</article-title><source>Clin. Pharmacol. Ther.</source><year>2005</year><volume>77</volume><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.clpt.2004.10.005</pub-id><pub-id pub-id-type="pmid">15735611</pub-id></element-citation></ref><ref id="B25-molecules-30-01676"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides</article-title><source>J. Clin. Pharmacol.</source><year>2009</year><volume>49</volume><fpage>1403</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1177/0091270009342251</pub-id><pub-id pub-id-type="pmid">19789373</pub-id></element-citation></ref><ref id="B26-molecules-30-01676"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cancalon</surname><given-names>P.</given-names></name><name name-style="western"><surname>Widmer</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>The effect of grapefruit juice on drug disposition</article-title><source>Expert. Opin. Drug Metab. Toxicol.</source><year>2011</year><volume>7</volume><fpage>267</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1517/17425255.2011.553189</pub-id><pub-id pub-id-type="pmid">21254874</pub-id><pub-id pub-id-type="pmcid">PMC3071161</pub-id></element-citation></ref><ref id="B27-molecules-30-01676"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Shon</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K.H.</given-names></name></person-group><article-title>Inhibitory effects of fruit juices on CYP3A activity</article-title><source>Drug Metab. Dispos.</source><year>2006</year><volume>34</volume><fpage>521</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1124/dmd.105.007930</pub-id><pub-id pub-id-type="pmid">16415112</pub-id></element-citation></ref><ref id="B28-molecules-30-01676"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Dresser</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Leake</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>R.B.</given-names></name></person-group><article-title>Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice</article-title><source>Clin. Pharmacol. Ther.</source><year>2007</year><volume>81</volume><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/sj.clpt.6100104</pub-id><pub-id pub-id-type="pmid">17301733</pub-id></element-citation></ref><ref id="B29-molecules-30-01676"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colalto</surname><given-names>C.</given-names></name></person-group><article-title>Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment</article-title><source>Pharmacol. Res.</source><year>2010</year><volume>62</volume><fpage>207</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2010.04.001</pub-id><pub-id pub-id-type="pmid">20399862</pub-id></element-citation></ref><ref id="B30-molecules-30-01676"><label>30.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>R.D.H.</given-names></name><name name-style="western"><surname>Mendez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>R.A.</given-names></name></person-group><source>The Natural Coumarins: Occurrence, Chemistry and Biochemistry</source><publisher-name>Wiley and Sons</publisher-name><publisher-loc>Chichester, UK</publisher-loc><year>1982</year></element-citation></ref><ref id="B31-molecules-30-01676"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venugopala</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Rashmi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Odhav</surname><given-names>B.</given-names></name></person-group><article-title>Review on natural coumarin lead compounds for their pharmacological activity</article-title><source>BioMed Res. Int.</source><year>2013</year><volume>2013</volume><elocation-id>963248</elocation-id><pub-id pub-id-type="doi">10.1155/2013/963248</pub-id><pub-id pub-id-type="pmid">23586066</pub-id><pub-id pub-id-type="pmcid">PMC3622347</pub-id></element-citation></ref><ref id="B32-molecules-30-01676"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Est&#233;vez-Braun</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>A.G.</given-names></name></person-group><article-title>Coumarins</article-title><source>Nat. Prod. Rep.</source><year>1997</year><volume>14</volume><fpage>465</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1039/np9971400465</pub-id><pub-id pub-id-type="pmid">9364778</pub-id></element-citation></ref><ref id="B33-molecules-30-01676"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourgaud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hehn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Larbat</surname><given-names>R.</given-names></name><name name-style="western"><surname>Doerper</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gontier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kellner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Matern</surname><given-names>U.</given-names></name></person-group><article-title>Biosynthesis of coumarins in plants: A major pathway still to be unravelled for cytochrome P450 enzymes</article-title><source>Phytochem. Rev.</source><year>2006</year><volume>5</volume><fpage>293</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1007/s11101-006-9040-2</pub-id></element-citation></ref><ref id="B34-molecules-30-01676"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munakata</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kitajima</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nuttens</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tatsumi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Takemura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ichino</surname><given-names>T.</given-names></name><name name-style="western"><surname>Galati</surname><given-names>G.</given-names></name><name name-style="western"><surname>Vautrin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Berg&#232;s</surname><given-names>H.</given-names></name><name name-style="western"><surname>Grosjean</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Convergent evolution of the UbiA prenyltransferase family underlies the independent acquisition of furanocoumarins in plants</article-title><source>New Phytol.</source><year>2020</year><volume>225</volume><fpage>2166</fpage><lpage>2182</lpage><pub-id pub-id-type="doi">10.1111/nph.16277</pub-id><pub-id pub-id-type="pmid">31642055</pub-id><pub-id pub-id-type="pmcid">PMC7028039</pub-id></element-citation></ref><ref id="B35-molecules-30-01676"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pathak</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>F.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Fitzpatrick</surname><given-names>T.B.</given-names></name></person-group><article-title>The presently known distribution of furocoumarins (psoralens) in plants</article-title><source>J. Investig. Dermatol.</source><year>1962</year><volume>39</volume><fpage>225</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1038/jid.1962.106</pub-id><pub-id pub-id-type="pmid">13941836</pub-id></element-citation></ref><ref id="B36-molecules-30-01676"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bourgaud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Allard</surname><given-names>N.</given-names></name><name name-style="western"><surname>Guckert</surname><given-names>A.</given-names></name><name name-style="western"><surname>Forlot</surname><given-names>P.</given-names></name></person-group><source>Natural Sources for Furocoumarins</source><publisher-name>John Libbey Eurotext, Ltd.</publisher-name><publisher-loc>Paris, France</publisher-loc><year>1989</year><fpage>301</fpage><lpage>306</lpage></element-citation></ref><ref id="B37-molecules-30-01676"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Seigler</surname><given-names>D.S.</given-names></name></person-group><source>Plant Secondary Metabolism</source><publisher-name>Springer Science &amp; Business Media</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1998</year></element-citation></ref><ref id="B38-molecules-30-01676"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Barreca</surname><given-names>D.</given-names></name><name name-style="western"><surname>Protti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brighenti</surname><given-names>V.</given-names></name><name name-style="western"><surname>Righetti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Anceschi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mercolini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Benvenuti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gattuso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pellati</surname><given-names>F.</given-names></name></person-group><article-title>Botanical sources, chemistry, analysis, and biological activity of furanocoumarins of pharmaceutical interest</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2163</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24112163</pub-id><pub-id pub-id-type="pmid">31181737</pub-id><pub-id pub-id-type="pmcid">PMC6600687</pub-id></element-citation></ref><ref id="B39-molecules-30-01676"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berenbaum</surname><given-names>M.</given-names></name></person-group><article-title>Coumarins and caterpillars: A case for coevolution</article-title><source>Evolution</source><year>1983</year><volume>37</volume><fpage>163</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.2307/2408184</pub-id><pub-id pub-id-type="pmid">28568024</pub-id></element-citation></ref><ref id="B40-molecules-30-01676"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peroutka</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schulzov&#225;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Botek</surname><given-names>P.</given-names></name><name name-style="western"><surname>Haj&#353;lov&#225;</surname><given-names>J.</given-names></name></person-group><article-title>Analysis of furanocoumarins in vegetables (Apiaceae) and citrus fruits (Rutaceae)</article-title><source>J. Sci. Food Agric.</source><year>2007</year><volume>87</volume><fpage>2152</fpage><lpage>2163</lpage><pub-id pub-id-type="doi">10.1002/jsfa.2979</pub-id></element-citation></ref><ref id="B41-molecules-30-01676"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karamat</surname><given-names>F.</given-names></name><name name-style="western"><surname>Olry</surname><given-names>A.</given-names></name><name name-style="western"><surname>Munakata</surname><given-names>R.</given-names></name><name name-style="western"><surname>Koeduka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paris</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hehn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bourgaud</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yazaki</surname><given-names>K.</given-names></name></person-group><article-title>A coumarinspecific prenyltransferase catalyzes the crucial biosynthetic reaction for furanocoumarin formation in parsley</article-title><source>Plant J.</source><year>2014</year><volume>77</volume><fpage>627</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1111/tpj.12409</pub-id><pub-id pub-id-type="pmid">24354545</pub-id></element-citation></ref><ref id="B42-molecules-30-01676"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dugrand</surname><given-names>A.</given-names></name><name name-style="western"><surname>Olry</surname><given-names>A.</given-names></name><name name-style="western"><surname>Duval</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hehn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Froelicher</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bourgaud</surname><given-names>F.</given-names></name></person-group><article-title>Coumarin and furanocoumarin quantitation in Citrus peel via Ultraperformance Liquid Chromatography coupled with Mass Spectrometry (UPLC-MS)</article-title><source>J. Agric. Food. Chem.</source><year>2013</year><volume>61</volume><fpage>10677</fpage><lpage>10684</lpage><pub-id pub-id-type="doi">10.1021/jf402763t</pub-id><pub-id pub-id-type="pmid">24117278</pub-id></element-citation></ref><ref id="B43-molecules-30-01676"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>W.-L.</given-names></name><name name-style="western"><surname>Suh</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Chemistry and health effects of furanocoumarins in grapefruit</article-title><source>J. Food Drug Anal. (JFDA)</source><year>2017</year><volume>25</volume><fpage>71</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jfda.2016.11.008</pub-id><pub-id pub-id-type="pmid">28911545</pub-id><pub-id pub-id-type="pmcid">PMC9333421</pub-id></element-citation></ref><ref id="B44-molecules-30-01676"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mallhi</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Sarriff</surname><given-names>A.</given-names></name><name name-style="western"><surname>Adnan</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Qadir</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Hamzah</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.H.</given-names></name></person-group><article-title>Effect of Fruit/Vegetable-Drug Interactions on CYP450, OATP and p-Glycoprotein: A Systematic Review</article-title><source>Trop. J. Pharm. Res.</source><year>2015</year><volume>14</volume><fpage>1927</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v14i10.27</pub-id></element-citation></ref><ref id="B45-molecules-30-01676"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudarshan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Aidhen</surname><given-names>I.S.</given-names></name></person-group><article-title>Convenient Synthesis of 3-Glycosylated Isocoumarins</article-title><source>Eur. J. Org. Chem.</source><year>2017</year><volume>2017</volume><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201601264</pub-id></element-citation></ref><ref id="B46-molecules-30-01676"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramanan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sudarshan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Aidhen</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Doble</surname><given-names>M.</given-names></name></person-group><article-title>Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins</article-title><source>Eur. J. Med. Chem.</source><year>2016</year><volume>124</volume><fpage>428</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2016.08.066</pub-id><pub-id pub-id-type="pmid">27597418</pub-id></element-citation></ref><ref id="B47-molecules-30-01676"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M.H.</given-names></name></person-group><article-title>A multi-faceted comparison of phytochemicals in seven citrus peels and improvement of chemical composition and antioxidant ativity by steaming</article-title><source>LWT</source><year>2022</year><volume>160</volume><fpage>113297</fpage><pub-id pub-id-type="doi">10.1016/j.lwt.2022.113297</pub-id></element-citation></ref><ref id="B48-molecules-30-01676"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lilja</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Juntti-Patinen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Neuvonen</surname><given-names>P.J.</given-names></name></person-group><article-title>Orange juice substantially reduces the bioavailability of the betaadrenergic-blocking agent celiprolol</article-title><source>Clin. Pharmacol. Ther.</source><year>2004</year><volume>75</volume><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.clpt.2003.11.002</pub-id><pub-id pub-id-type="pmid">15001969</pub-id></element-citation></ref><ref id="B49-molecules-30-01676"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ieiri</surname><given-names>I.</given-names></name><name name-style="western"><surname>Doi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hirota</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chiyoda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Miyagawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Irie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Microdosing clinical study: Pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose</article-title><source>J. Clin. Pharmacol.</source><year>2012</year><volume>52</volume><fpage>1078</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1177/0091270011408612</pub-id><pub-id pub-id-type="pmid">21593283</pub-id></element-citation></ref><ref id="B50-molecules-30-01676"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhotra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Paine</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>P.B.</given-names></name></person-group><article-title>Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins</article-title><source>Clin. Pharmacol. Ther.</source><year>2001</year><volume>69</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1067/mcp.2001.113185</pub-id><pub-id pub-id-type="pmid">11180034</pub-id></element-citation></ref><ref id="B51-molecules-30-01676"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penzak</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Jann</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Cold</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hon</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Desai</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Gurley</surname><given-names>B.J.</given-names></name></person-group><article-title>Seville (sour) Orange Juice: Synephrine Content and Cardiovascular Effects in Normotensive Adults</article-title><source>J. Clin. Pharmacol.</source><year>2001</year><volume>41</volume><fpage>1059</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1177/00912700122012652</pub-id><pub-id pub-id-type="pmid">11583473</pub-id></element-citation></ref><ref id="B52-molecules-30-01676"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adegoke</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Oyelami</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Olatunya</surname><given-names>O.S.</given-names></name><name name-style="western"><surname>Adeyemi</surname><given-names>L.A.</given-names></name></person-group><article-title>Effects of lime juice on malaria parasite clearance</article-title><source>Phytother. Res.</source><year>2011</year><volume>25</volume><fpage>1547</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1002/ptr.3418</pub-id><pub-id pub-id-type="pmid">21413089</pub-id></element-citation></ref><ref id="B53-molecules-30-01676"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karmakar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bera</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kundu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Sen</surname><given-names>T.</given-names></name></person-group><article-title>Beverage-induced enhanced bioavailability of carbamazepine and its consequent effect on antiepileptic activity and toxicity</article-title><source>J. Food Drug Anal.</source><year>2015</year><volume>23</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.jfda.2014.07.012</pub-id><pub-id pub-id-type="pmid">28911389</pub-id><pub-id pub-id-type="pmcid">PMC9351769</pub-id></element-citation></ref><ref id="B54-molecules-30-01676"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Russo</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Grazia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grasso</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dugo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>L.</given-names></name></person-group><article-title>Thorough investigation of the oxygen heterocyclic fraction of lime (<italic toggle="yes">Citrus aurantifolia</italic> (Christm.) Swingle) juice</article-title><source>J. Sep. Sci.</source><year>2014</year><volume>37</volume><fpage>792</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1002/jssc.201300986</pub-id><pub-id pub-id-type="pmid">24478239</pub-id></element-citation></ref><ref id="B55-molecules-30-01676"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Ghazawi</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Tutunji</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>AbuRuz</surname><given-names>S.M.</given-names></name></person-group><article-title>The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers</article-title><source>Eur. J. Clin. Pharmacol.</source><year>2010</year><volume>66</volume><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1007/s00228-009-0738-0</pub-id><pub-id pub-id-type="pmid">19830413</pub-id></element-citation></ref><ref id="B56-molecules-30-01676"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.R.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Glycemic index, glycemic load, and glycemic response to pomelo in patients with type 2 diabetes</article-title><source>J. Huazhong Univ. Sci. Technol. Med. Sci.</source><year>2017</year><volume>37</volume><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1007/s11596-017-1793-x</pub-id><pub-id pub-id-type="pmid">29058284</pub-id></element-citation></ref><ref id="B57-molecules-30-01676"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anmol</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Marium</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hiew</surname><given-names>F.T.</given-names></name><name name-style="western"><surname>Han</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>L.K.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>A.K.Y.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sarker</surname><given-names>M.M.R.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Kifli</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Phytochemical and Therapeutic Potential of Citrus grandis (L.) Osbeck: A Review</article-title><source>J. Evid. Based. Integr. Med.</source><year>2021</year><volume>26</volume><fpage>2515690X211043741</fpage><pub-id pub-id-type="doi">10.1177/2515690X211043741</pub-id><pub-id pub-id-type="pmid">34657477</pub-id><pub-id pub-id-type="pmcid">PMC8527587</pub-id></element-citation></ref><ref id="B58-molecules-30-01676"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Messire</surname><given-names>G.</given-names></name><name name-style="western"><surname>Serreau</surname><given-names>R.</given-names></name><name name-style="western"><surname>Berteina-Raboin</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant Effects of Catechins (EGCG),Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update</article-title><source>Antioxidants</source><year>2023</year><volume>12</volume><elocation-id>1317</elocation-id><pub-id pub-id-type="doi">10.3390/antiox12071317</pub-id><pub-id pub-id-type="pmid">37507856</pub-id><pub-id pub-id-type="pmcid">PMC10376544</pub-id></element-citation></ref><ref id="B59-molecules-30-01676"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumgartner</surname><given-names>B.</given-names></name><name name-style="western"><surname>Erdelmeier</surname><given-names>C.A.J.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Rali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sticher</surname><given-names>O.</given-names></name></person-group><article-title>An antimicrobial alkaloid from Ficus septica</article-title><source>Phytochemistry</source><year>1990</year><volume>29</volume><fpage>3327</fpage><lpage>3330</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(90)80209-Y</pub-id></element-citation></ref><ref id="B60-molecules-30-01676"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Khdhairawi</surname><given-names>A.A.Q.</given-names></name><name name-style="western"><surname>Krishnan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mai</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Leong</surname><given-names>C.O.</given-names></name><name name-style="western"><surname>Yong</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Chong</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Low</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Kam</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>K.H.</given-names></name></person-group><article-title>A Bis-benzopyrroloisoquinoline Alkaloid Incorporating a Cyclobutane Core and a Chlorophenanthroindolizidine Alkaloid with Cytotoxic Activity from <italic toggle="yes">Ficus fistulosa var</italic>. tengerensis</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>2734</fpage><lpage>2740</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00500</pub-id><pub-id pub-id-type="pmid">28926237</pub-id></element-citation></ref><ref id="B61-molecules-30-01676"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>T.J.P.</given-names></name><name name-style="western"><surname>Ramachandran</surname><given-names>V.</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>P.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>W.F.</given-names></name></person-group><article-title>Investigation of antibacterial phytochemicals in the bark and leaves of Ficus coronata by high-performance liquid chromatography-electrospray ionization-ion trap mass spectrometry (HPLC-ESI-MSn) and ESI-MSn</article-title><source>Electrophoresis</source><year>2012</year><volume>33</volume><fpage>713</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1002/elps.201100302</pub-id><pub-id pub-id-type="pmid">22451065</pub-id></element-citation></ref><ref id="B62-molecules-30-01676"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yap</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Loong</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Ting</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Loh</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Yong</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Low</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Kam</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>K.H.</given-names></name></person-group><article-title>Hispidacine, an unusual 8,4&#8217;-oxyneolignan-alkaloid with vasorelaxant activity, and hispiloscine, an antiproliferative phenanthroindolizidine alkaloid, from Ficus hispida Linn</article-title><source>Phytochemistry</source><year>2015</year><volume>109</volume><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2014.10.032</pub-id><pub-id pub-id-type="pmid">25468714</pub-id></element-citation></ref><ref id="B63-molecules-30-01676"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yap</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Qazzaz</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Raja</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Bradshaw</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Loh</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Sim</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Yong</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Low</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>K.H.</given-names></name></person-group><article-title>Fistulopsines A and B antiproliferative septicine-type alkaloids from Ficus fistulosa</article-title><source>Phytochem. Lett.</source><year>2016</year><volume>15</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2015.12.007</pub-id></element-citation></ref><ref id="B64-molecules-30-01676"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubnov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kashman</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rabinowitz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schlesinger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group><article-title>Suppressors of cancer cell proliferation from fig (<italic toggle="yes">Ficus carica</italic>) resin: Isolation and structure elucidation</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>993</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1021/np000592z</pub-id><pub-id pub-id-type="pmid">11473446</pub-id></element-citation></ref><ref id="B65-molecules-30-01676"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saeed</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Sabir</surname><given-names>A.W.</given-names></name></person-group><article-title>Irritant potential of triterpenoids from Ficus carica leaves</article-title><source>Fitoterapia</source><year>2002</year><volume>73</volume><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(02)00127-2</pub-id><pub-id pub-id-type="pmid">12165340</pub-id></element-citation></ref><ref id="B66-molecules-30-01676"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ojo</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Ajiboye</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Ojo</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Onikanni</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Olarewaju</surname><given-names>O.I.</given-names></name></person-group><article-title>Phytochemical, proximate analysis and mineral composition of aqueous crude extract of <italic toggle="yes">Ficus asperifolia Miq</italic></article-title><source>J. Adv. Med. Life. Sci.</source><year>2014</year><volume>1</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.5281/zenodo.1000388</pub-id></element-citation></ref><ref id="B67-molecules-30-01676"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Baptista</surname><given-names>P.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>J.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Valentao</surname><given-names>P.</given-names></name></person-group><article-title>Characterization of <italic toggle="yes">Ficus carica</italic> L. cultivars by DNA and secondary metabolite analysis: Is genetic diversity reflected in the chemical composition?</article-title><source>Food Res. Int.</source><year>2012</year><volume>49</volume><fpage>710</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2012.09.019</pub-id></element-citation></ref><ref id="B68-molecules-30-01676"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ojala</surname><given-names>T.</given-names></name><name name-style="western"><surname>Remes</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haansuu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vuorela</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hiltunen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Haahtela</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vuorela</surname><given-names>P.</given-names></name></person-group><article-title>Antimicrobial activity of some coumarin containing herbal plants growing in Finland</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>73</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00279-8</pub-id><pub-id pub-id-type="pmid">11025169</pub-id></element-citation></ref><ref id="B69-molecules-30-01676"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Okiura</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kohno</surname><given-names>M.</given-names></name></person-group><article-title>Identification of phenylpropanoids in fig (<italic toggle="yes">Ficus carica</italic> L.) leaves</article-title><source>J. Agric. Food Chem.</source><year>2014</year><volume>62</volume><fpage>10076</fpage><lpage>10083</lpage><pub-id pub-id-type="doi">10.1021/jf5025938</pub-id><pub-id pub-id-type="pmid">25198243</pub-id></element-citation></ref><ref id="B70-molecules-30-01676"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Okiura</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kohno</surname><given-names>M.</given-names></name></person-group><article-title>Phenylpropanoid composition in fig (<italic toggle="yes">Ficus carica</italic> L.) leaves</article-title><source>J. Nat. Med.</source><year>2017</year><volume>71</volume><fpage>770</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1007/s11418-017-1093-6</pub-id><pub-id pub-id-type="pmid">28589249</pub-id></element-citation></ref><ref id="B71-molecules-30-01676"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debib</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tir-Touil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mothana</surname><given-names>R.A.A.</given-names></name><name name-style="western"><surname>Meddah</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sonnet</surname><given-names>P.</given-names></name></person-group><article-title>Phenolic content, antioxidant and antimicrobial activities of two fruit varieties of Algerian <italic toggle="yes">Ficus carica</italic> L</article-title><source>J. Food. Biochem.</source><year>2013</year><volume>38</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/jfbc.12039</pub-id></element-citation></ref><ref id="B72-molecules-30-01676"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ramiro</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Romero</surname><given-names>A.</given-names></name><name name-style="western"><surname>Campillo</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>M.D.</given-names></name></person-group><article-title>A study on the glycaemic balance in streptozotocin diabetic rats treated with aqueous extract of <italic toggle="yes">Ficus carica</italic> (Fig tree) leaves</article-title><source>Phytother Res.</source><year>1996</year><volume>10</volume><fpage>82</fpage><lpage>83</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1573(199602)10:1&amp;#x0003c;82::AID-PTR776&amp;#x0003e;3.0.CO;2-R</pub-id></element-citation></ref><ref id="B73-molecules-30-01676"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irudayaraj</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Christudas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Antony</surname><given-names>S.</given-names></name><name name-style="western"><surname>Duraipandiyan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Naif Abdullah</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Ignacimuthu</surname><given-names>S.</given-names></name></person-group><article-title>Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and &#946;-cells in type 2 diabetic rats</article-title><source>Pharm. Biol.</source><year>2017</year><volume>55</volume><fpage>1074</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1080/13880209.2017.1279671</pub-id><pub-id pub-id-type="pmid">28193094</pub-id><pub-id pub-id-type="pmcid">PMC6130661</pub-id></element-citation></ref><ref id="B74-molecules-30-01676"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Functions, accumulation, and biosynthesis of important secondary metabolites in the fig tree (<italic toggle="yes">Ficus carica</italic>)</article-title><source>Front. Plant Sci.</source><year>2024</year><volume>15</volume><elocation-id>1397874</elocation-id><pub-id pub-id-type="doi">10.3389/fpls.2024.1397874</pub-id><pub-id pub-id-type="pmid">39022605</pub-id><pub-id pub-id-type="pmcid">PMC11253076</pub-id></element-citation></ref><ref id="B75-molecules-30-01676"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gai</surname><given-names>Q.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.J.</given-names></name></person-group><article-title>Enhanced and green extraction polyphenols and furanocoumarins from Fig (<italic toggle="yes">Ficus carica</italic> L.) leaves using deep eutectic solvents</article-title><source>.J. Pharm. Biomed. Anal.</source><year>2017</year><volume>145</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2017.07.002</pub-id><pub-id pub-id-type="pmid">28710995</pub-id></element-citation></ref><ref id="B76-molecules-30-01676"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamoucha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fokialakis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Christodoulakis</surname><given-names>N.S.</given-names></name></person-group><article-title>Leaf structure and histochemistry of <italic toggle="yes">Ficus carica</italic> (<italic toggle="yes">Moraceae</italic>), the fig tree</article-title><source>Flora</source><year>2016</year><volume>218</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.flora.2015.11.003</pub-id></element-citation></ref><ref id="B77-molecules-30-01676"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Statti</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Bonesi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Duez</surname><given-names>P.</given-names></name><name name-style="western"><surname>Menichini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Conforti</surname><given-names>F.</given-names></name></person-group><article-title>Changes in the phenolic and lipophilic composition, in the enzyme inhibition and antiproliferative activity of <italic toggle="yes">Ficus carica</italic> L. cultivar Dottato fruits during maturation</article-title><source>Food Chem. Toxicol.</source><year>2012</year><volume>50</volume><fpage>726</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2011.12.025</pub-id><pub-id pub-id-type="pmid">22222929</pub-id></element-citation></ref><ref id="B78-molecules-30-01676"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Bhagchandani</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>N.</given-names></name></person-group><article-title>New furanocoumarins and other chemical constituents from <italic toggle="yes">Ficus carica</italic> root heartwood</article-title><source>Z. Naturforsch. C J. Biosci.</source><year>2013</year><volume>68</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.5560/ZNC.2013.68c0003</pub-id><pub-id pub-id-type="pmid">23659166</pub-id></element-citation></ref><ref id="B79-molecules-30-01676"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramappa</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>D.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>U.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gosipatala</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Saha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Raj</surname><given-names>R.</given-names></name></person-group><article-title>Mulberries: A promising fruit for phytochemicals, nutracicals and biological activities</article-title><source>Int. J. Fruit Sci.</source><year>2020</year><volume>20</volume><fpage>S1254</fpage><lpage>S1279</lpage><pub-id pub-id-type="doi">10.1080/15538362.2020.1784075</pub-id></element-citation></ref><ref id="B80-molecules-30-01676"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budiman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aulifa</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Kusuma</surname><given-names>A.S.W.</given-names></name><name name-style="western"><surname>Sulastri</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial and antioxidant activity of black mulberry (<italic toggle="yes">Morus nigra</italic>) extracts for acne treatment</article-title><source>Pharmacog. J.</source><year>2017</year><volume>9</volume><fpage>611</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.5530/pj.2017.5.97</pub-id></element-citation></ref><ref id="B81-molecules-30-01676"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>He</surname><given-names>N.</given-names></name></person-group><article-title>Anti-inflammatory and antinociceptive properties of flavonoids from the fruits of black mulberry (<italic toggle="yes">Morus nigra</italic> L.)</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0153080</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0153080</pub-id><pub-id pub-id-type="pmid">27046026</pub-id><pub-id pub-id-type="pmcid">PMC4821529</pub-id></element-citation></ref><ref id="B82-molecules-30-01676"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isabelle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Ong</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D.</given-names></name></person-group><article-title>Peroxyl radical scavenging capacity, polyphenolics, and lipophilic antioxidant profiles of mulberry fruits cultivated in southern China</article-title><source>J. Agric. Food Chem.</source><year>2008</year><volume>56</volume><fpage>9410</fpage><lpage>9416</lpage><pub-id pub-id-type="doi">10.1021/jf801527a</pub-id><pub-id pub-id-type="pmid">18817415</pub-id></element-citation></ref><ref id="B83-molecules-30-01676"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deniz</surname><given-names>G.Y.</given-names></name><name name-style="western"><surname>Laloglu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Koc</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nadaroglu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Geyikoglu</surname><given-names>F.</given-names></name></person-group><article-title>The effect of black mulberry (<italic toggle="yes">Morus nigra</italic>) extracts on carbon tetrachloride-induced liver damage</article-title><source>Arch. Biol. Sci.</source><year>2018</year><volume>70</volume><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.2298/ABS171009055D</pub-id></element-citation></ref><ref id="B84-molecules-30-01676"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name></person-group><article-title>The mulberry (<italic toggle="yes">Morus alba</italic> L.) fruit: A review of characteristic components and health benefits</article-title><source>J. Agric. Food Chem.</source><year>2017</year><volume>65</volume><fpage>10383</fpage><lpage>10394</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b03614</pub-id><pub-id pub-id-type="pmid">29129054</pub-id></element-citation></ref><ref id="B85-molecules-30-01676"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>P.W.</given-names></name><name name-style="western"><surname>Shia</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Chao</surname><given-names>P.D.L.</given-names></name><name name-style="western"><surname>Juang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y.C.</given-names></name></person-group><article-title>Potential Risk of Mulberry&#8211;Drug Interaction: Modulation on P-Glycoprotein and Cytochrome P450 3A</article-title><source>J. Agric. Food Chem.</source><year>2013</year><volume>61</volume><fpage>4464</fpage><lpage>4469</lpage><pub-id pub-id-type="doi">10.1021/jf3052384</pub-id><pub-id pub-id-type="pmid">23590720</pub-id></element-citation></ref><ref id="B86-molecules-30-01676"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fredericks</surname><given-names>S.</given-names></name><name name-style="western"><surname>Holt</surname><given-names>D.W.</given-names></name></person-group><article-title>Pharmacogenomics of immunosuppressive drug metabolism</article-title><source>Curr. Opin. Nephrol. Hypertens.</source><year>2003</year><volume>12</volume><fpage>607</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1097/00041552-200311000-00006</pub-id><pub-id pub-id-type="pmid">14564197</pub-id></element-citation></ref><ref id="B87-molecules-30-01676"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lown</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Mayo</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Leichtman</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Turgeon</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Schmiedlin-Ren</surname><given-names>P.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Benet</surname><given-names>L.Z.</given-names></name><etal/></person-group><article-title>Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine</article-title><source>Clin. Pharmacol. Ther.</source><year>1997</year><volume>62</volume><fpage>248</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/S0009-9236(97)90027-8</pub-id><pub-id pub-id-type="pmid">9333100</pub-id></element-citation></ref><ref id="B88-molecules-30-01676"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheu</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Liou</surname><given-names>Y.B.</given-names></name><name name-style="western"><surname>Kao</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>H.O.</given-names></name></person-group><article-title>A quantitative structure-activity relationship for the modulation effects of flavonoids on p-glycoprotein-mediated transport</article-title><source>Chem. Pharm. Bull.</source><year>2010</year><volume>58</volume><fpage>1187</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1248/cpb.58.1187</pub-id><pub-id pub-id-type="pmid">20823598</pub-id></element-citation></ref><ref id="B89-molecules-30-01676"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Real</surname><given-names>R.</given-names></name><name name-style="western"><surname>P&#233;rez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mendoza</surname><given-names>G.</given-names></name><name name-style="western"><surname>Prieto</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Merino</surname><given-names>G.</given-names></name></person-group><article-title>Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response</article-title><source>J. Pharm. Sci.</source><year>2010</year><volume>99</volume><fpage>598</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1002/jps.21851</pub-id><pub-id pub-id-type="pmid">19544374</pub-id></element-citation></ref><ref id="B90-molecules-30-01676"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hatano</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.10.041</pub-id><pub-id pub-id-type="pmid">19883715</pub-id></element-citation></ref><ref id="B91-molecules-30-01676"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sergent</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dupont</surname><given-names>I.</given-names></name><name name-style="western"><surname>Van der Heiden</surname><given-names>E.</given-names></name><name name-style="western"><surname>Scippo</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Pussemier</surname><given-names>L.</given-names></name><name name-style="western"><surname>Larondelle</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>Y.J.</given-names></name></person-group><article-title>CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells</article-title><source>Toxicol. Lett.</source><year>2009</year><volume>191</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2009.09.002</pub-id><pub-id pub-id-type="pmid">19766177</pub-id></element-citation></ref><ref id="B92-molecules-30-01676"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>A.K.</given-names></name></person-group><article-title>MDR- and CYP3A4-mediated drug&#8722;herbal interactions</article-title><source>Life Sci.</source><year>2006</year><volume>78</volume><fpage>2131</fpage><lpage>2145</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.12.010</pub-id><pub-id pub-id-type="pmid">16442130</pub-id></element-citation></ref><ref id="B93-molecules-30-01676"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Piao</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>K.W.</given-names></name></person-group><article-title>Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin</article-title><source>Arch. Pharm. Res.</source><year>2011</year><volume>34</volume><fpage>607</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1007/s12272-011-0411-x</pub-id><pub-id pub-id-type="pmid">21544726</pub-id></element-citation></ref><ref id="B94-molecules-30-01676"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Chao</surname><given-names>P.D.</given-names></name></person-group><article-title>Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4</article-title><source>J. Agric. Food. Chem.</source><year>2011</year><volume>59</volume><fpage>4644</fpage><lpage>4648</lpage><pub-id pub-id-type="doi">10.1021/jf104786t</pub-id><pub-id pub-id-type="pmid">21466223</pub-id></element-citation></ref><ref id="B95-molecules-30-01676"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akamine</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Komori</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kusuhara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tamai</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ieiri</surname><given-names>I.</given-names></name><name name-style="western"><surname>Uno</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yasui-Furukori</surname><given-names>N.</given-names></name></person-group><article-title>Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers</article-title><source>Eur. J. Clin. Pharmacol.</source><year>2014</year><volume>70</volume><fpage>1087</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1007/s00228-014-1705-y</pub-id><pub-id pub-id-type="pmid">24903351</pub-id></element-citation></ref><ref id="B96-molecules-30-01676"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guyot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Marnet</surname><given-names>N.</given-names></name><name name-style="western"><surname>Laraba</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sanover</surname><given-names>P.</given-names></name><name name-style="western"><surname>Drilleau</surname><given-names>J.F.</given-names></name></person-group><article-title>Reversed-phase HPLC following thiolysis for quantitative estimation and characterization of the four main classes of phenolic compounds in different tissue zones of a French cider apple variety (<italic toggle="yes">Malus domestica</italic>) var. Kermerrien)</article-title><source>J. Agric. Food Chem.</source><year>1998</year><volume>46</volume><fpage>1698</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.1021/jf970832p</pub-id></element-citation></ref><ref id="B97-molecules-30-01676"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zessner</surname><given-names>H.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Will</surname><given-names>F.</given-names></name><name name-style="western"><surname>Klimo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Knauft</surname><given-names>J.</given-names></name><name name-style="western"><surname>Niewohner</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hummer</surname><given-names>W.</given-names></name><name name-style="western"><surname>Owen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Richling</surname><given-names>E.</given-names></name><name name-style="western"><surname>Frank</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential</article-title><source>Mol. Nutr. Food Res.</source><year>2008</year><volume>52</volume><fpage>S28</fpage><lpage>S44</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200700317</pub-id><pub-id pub-id-type="pmid">18398871</pub-id></element-citation></ref><ref id="B98-molecules-30-01676"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mimura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yasujima</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>K.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yuasa</surname><given-names>H.</given-names></name></person-group><article-title>Functional Identification of Plasma Membrane Monoamine Transporter (PMAT/SLC29A4) as an Atenolol Transporter Sensitive to Flavonoids Contained in Apple Juice</article-title><source>J. Pharm. Sci.</source><year>2017</year><volume>106</volume><fpage>2592</fpage><lpage>2598</lpage><pub-id pub-id-type="doi">10.1016/j.xphs.2017.01.009</pub-id><pub-id pub-id-type="pmid">28089688</pub-id></element-citation></ref><ref id="B99-molecules-30-01676"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imanaga</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kotegawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Imai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tsutsumi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yoshizato</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohyama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shirasaka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tamai</surname><given-names>I.</given-names></name><name name-style="western"><surname>Tateishi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohashi</surname><given-names>K.</given-names></name></person-group><article-title>The effects of the SLCO2B1 c.1457C &gt; T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans</article-title><source>Pharmacogenet. Genom.</source><year>2011</year><volume>21</volume><fpage>84</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/FPC.0b013e32834300cc</pub-id><pub-id pub-id-type="pmid">21280267</pub-id></element-citation></ref><ref id="B100-molecules-30-01676"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Melgarejo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tomas-Barberan</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Artes</surname><given-names>F.</given-names></name></person-group><article-title>Evolution of juice anthocyanins during ripening of new selected pomegranate (<italic toggle="yes">Punica granatum</italic>) clones</article-title><source>Eur. Food Res. Technol.</source><year>1999</year><volume>210</volume><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s002170050529</pub-id></element-citation></ref><ref id="B101-molecules-30-01676"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name></person-group><article-title>Modulation of P-glycoprotein function and reversal of multidrug resistance by (&#8722;)-epigallocatechin gallate in human cancer cells</article-title><source>Biomed. Pharmacother.</source><year>2005</year><volume>59</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2005.01.002</pub-id><pub-id pub-id-type="pmid">15795098</pub-id></element-citation></ref><ref id="B102-molecules-30-01676"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Seeram</surname><given-names>N.P.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Takada</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sand</surname><given-names>D.</given-names></name><name name-style="western"><surname>Heber</surname><given-names>D.</given-names></name></person-group><article-title>Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>980</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1021/jf052005r</pub-id><pub-id pub-id-type="pmid">16448212</pub-id></element-citation></ref><ref id="B103-molecules-30-01676"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Masse</surname><given-names>G.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Court</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>Pomegranate juice and pomegranate extract do not impair oral clearance of flurbiprofen in human volunteers: Divergence from in vitro results</article-title><source>Clin. Pharmacol. Ther.</source><year>2012</year><volume>92</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/clpt.2012.170</pub-id><pub-id pub-id-type="pmid">23047652</pub-id><pub-id pub-id-type="pmcid">PMC6170196</pub-id></element-citation></ref><ref id="B104-molecules-30-01676"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misaka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>R.</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>S.</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Inui</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kosuge</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>H.</given-names></name></person-group><article-title>Effect of 2 weeks&#8217; consumption of pomegranate juice on the pharmacokinetics of a single dose of midazolam: An open-label, randomized, single-center, 2-period crossover study in healthy Japanese volunteers</article-title><source>Clin. Ther.</source><year>2011</year><volume>33</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2011.02.012</pub-id><pub-id pub-id-type="pmid">21497708</pub-id></element-citation></ref><ref id="B105-molecules-30-01676"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farkas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Oleson</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Zinny</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Court</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: Comparison with grapefruit juice</article-title><source>J. Clin. Pharmacol.</source><year>2007</year><volume>47</volume><fpage>286</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1177/0091270006298359</pub-id><pub-id pub-id-type="pmid">17322140</pub-id></element-citation></ref><ref id="B106-molecules-30-01676"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shema-Didi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kristal</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ore</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>G.</given-names></name><name name-style="western"><surname>Geron</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sela</surname><given-names>S.</given-names></name></person-group><article-title>Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis</article-title><source>Nutr. Res.</source><year>2013</year><volume>33</volume><fpage>442</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2013.04.004</pub-id><pub-id pub-id-type="pmid">23746559</pub-id></element-citation></ref><ref id="B107-molecules-30-01676"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lilja</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Backman</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Neuvonen</surname><given-names>P.J.</given-names></name></person-group><article-title>Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam&#8211;probes of CYP2C9, CYP1A2, and CYP3A4</article-title><source>Clin. Pharmacol. Ther.</source><year>2007</year><volume>81</volume><fpage>833</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1038/sj.clpt.6100149</pub-id><pub-id pub-id-type="pmid">17392729</pub-id></element-citation></ref><ref id="B108-molecules-30-01676"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansell</surname><given-names>J.</given-names></name><name name-style="western"><surname>McDonough</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>The absence of an interaction between warfarin and cranberry juice: A randomized, double-blind trial</article-title><source>J. Clin. Pharmacol.</source><year>2009</year><volume>49</volume><fpage>824</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1177/0091270009337510</pub-id><pub-id pub-id-type="pmid">19553405</pub-id></element-citation></ref><ref id="B109-molecules-30-01676"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Seeram</surname><given-names>N.P.</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Thames</surname><given-names>G.</given-names></name><name name-style="western"><surname>Minutti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bowerman</surname><given-names>S.</given-names></name></person-group><article-title>Cranberry does not affect prothrombin time in male subjects on warfarin</article-title><source>J. Am. Diet. Assoc.</source><year>2006</year><volume>106</volume><fpage>2057</fpage><lpage>2061</lpage><pub-id pub-id-type="doi">10.1016/j.jada.2006.09.012</pub-id><pub-id pub-id-type="pmid">17126638</pub-id></element-citation></ref><ref id="B110-molecules-30-01676"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>von Moltke</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Perloff</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Zinny</surname><given-names>M.A.</given-names></name></person-group><article-title>Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies</article-title><source>Clin. Pharmacol. Ther.</source><year>2006</year><volume>79</volume><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.clpt.2005.09.014</pub-id><pub-id pub-id-type="pmid">16413247</pub-id></element-citation></ref><ref id="B111-molecules-30-01676"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shmuely</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yahav</surname><given-names>J.</given-names></name><name name-style="western"><surname>Samra</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chodick</surname><given-names>G.</given-names></name><name name-style="western"><surname>Koren</surname><given-names>R.</given-names></name><name name-style="western"><surname>Niv</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ofek</surname><given-names>I.</given-names></name></person-group><article-title>Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor</article-title><source>Mol. Nutr. Food Res.</source><year>2007</year><volume>51</volume><fpage>746</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200600281</pub-id><pub-id pub-id-type="pmid">17487928</pub-id></element-citation></ref><ref id="B112-molecules-30-01676"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nemzer</surname><given-names>B.V.</given-names></name><name name-style="western"><surname>Al-Taher</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yashin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Revelsky</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yashin</surname><given-names>Y.</given-names></name></person-group><article-title>Cranberry: Chemical Composition, Antioxidant Activity and Impact on Human Health: Overview</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>1503</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27051503</pub-id><pub-id pub-id-type="pmid">35268605</pub-id><pub-id pub-id-type="pmcid">PMC8911768</pub-id></element-citation></ref><ref id="B113-molecules-30-01676"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blumberg</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Camesano</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kris-Etherton</surname><given-names>P.</given-names></name><name name-style="western"><surname>Howell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manach</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ostertag</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Sies</surname><given-names>H.</given-names></name><name name-style="western"><surname>Skulas-Ray</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vita</surname><given-names>J.A.</given-names></name></person-group><article-title>Cranberries and their bioactive constituents in human health</article-title><source>Adv. Nutr.</source><year>2013</year><volume>4</volume><fpage>618</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.3945/an.113.004473</pub-id><pub-id pub-id-type="pmid">24228191</pub-id><pub-id pub-id-type="pmcid">PMC3823508</pub-id></element-citation></ref><ref id="B114-molecules-30-01676"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalt</surname><given-names>W.</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Krikorian</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stull</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Tremblay</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zamora-Ros</surname><given-names>R.</given-names></name></person-group><article-title>Recent Research on the Health Benefits of Blueberries and Their Anthocyanins</article-title><source>Adv. Nutr.</source><year>2020</year><volume>11</volume><fpage>224</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1093/advances/nmz065</pub-id><pub-id pub-id-type="pmid">31329250</pub-id><pub-id pub-id-type="pmcid">PMC7442370</pub-id></element-citation></ref><ref id="B115-molecules-30-01676"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Masse</surname><given-names>G.</given-names></name><name name-style="western"><surname>Harmatz</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Cancalon</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Dolnikowski</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Court</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Greenblatt</surname><given-names>D.J.</given-names></name></person-group><article-title>Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers</article-title><source>Br. J. Clin. Pharmacol.</source><year>2012</year><volume>75</volume><fpage>1041</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04450.x</pub-id><pub-id pub-id-type="pmid">22943633</pub-id><pub-id pub-id-type="pmcid">PMC3612722</pub-id></element-citation></ref><ref id="B116-molecules-30-01676"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>J.P.</given-names></name></person-group><article-title>Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease</article-title><source>Free Radic. Biol. Med.</source><year>2012</year><volume>52</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.09.010</pub-id><pub-id pub-id-type="pmid">21982844</pub-id></element-citation></ref><ref id="B117-molecules-30-01676"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez-Mateos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cifuentes-Gomez</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tabatabaee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lecras</surname><given-names>C.</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>J.P.</given-names></name></person-group><article-title>Procyanidin, anthocyanin, and chlorogenic acid contents of highbush and lowbush blueberries</article-title><source>J. Agric. Food Chem.</source><year>2012</year><volume>60</volume><fpage>5772</fpage><lpage>5778</lpage><pub-id pub-id-type="doi">10.1021/jf203812w</pub-id><pub-id pub-id-type="pmid">22175691</pub-id></element-citation></ref><ref id="B118-molecules-30-01676"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalt</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lawand</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>D.A.J.</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Forney</surname><given-names>C.F.</given-names></name></person-group><article-title>Oxygen radical absorbing capacity, anthocyanin and phenolic content of highbush blueberries (<italic toggle="yes">Vaccinium corymbosum</italic> L.) during ripening and storage</article-title><source>J. Am. Soc. Hortic. Sci.</source><year>2003</year><volume>128</volume><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.21273/JASHS.128.6.0917</pub-id></element-citation></ref><ref id="B119-molecules-30-01676"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pang</surname><given-names>L.</given-names></name></person-group><article-title>Blueberry Improves the Therapeutic Effect of Etanercept on Patients with Juvenile Idiopathic Arthritis: Phase III Study</article-title><source>Tohoku. J. Exp. Med.</source><year>2015</year><volume>237</volume><fpage>183</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1620/tjem.237.183</pub-id><pub-id pub-id-type="pmid">26477692</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-30-01676-f001" orientation="portrait"><label>Figure 1</label><caption><p>Main compounds involved in drug interactions found in grapefruit.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g001.jpg"/></fig><fig position="float" id="molecules-30-01676-f002" orientation="portrait"><label>Figure 2</label><caption><p>Typical classes of coumarins.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g002.jpg"/></fig><fig position="float" id="molecules-30-01676-f003" orientation="portrait"><label>Figure 3</label><caption><p>Various coumarin derivatives found in the citrus fruit family.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g003.jpg"/></fig><fig position="float" id="molecules-30-01676-f004" orientation="portrait"><label>Figure 4</label><caption><p>Various phenolic acids found in the citrus fruit family.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g004.jpg"/></fig><fig position="float" id="molecules-30-01676-f005" orientation="portrait"><label>Figure 5</label><caption><p>Various flavonoid glycosides found in the citrus fruit family.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g005.jpg"/></fig><fig position="float" id="molecules-30-01676-f006" orientation="portrait"><label>Figure 6</label><caption><p>Additional compounds found in orange.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g006.jpg"/></fig><fig position="float" id="molecules-30-01676-f007" orientation="portrait"><label>Figure 7</label><caption><p>Additional compounds found in lime.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g007.jpg"/></fig><fig position="float" id="molecules-30-01676-f008" orientation="portrait"><label>Figure 8</label><caption><p>Various additional compounds found in <italic toggle="yes">Citrus grandis</italic> L.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g008.jpg"/></fig><fig position="float" id="molecules-30-01676-f009" orientation="portrait"><label>Figure 9</label><caption><p>Some of the structures present in <italic toggle="yes">ficus carica</italic> that can induce drug interactions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g009.jpg"/></fig><fig position="float" id="molecules-30-01676-f010" orientation="portrait"><label>Figure 10</label><caption><p>Structures present in blackberry.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g010.jpg"/></fig><fig position="float" id="molecules-30-01676-f011" orientation="portrait"><label>Figure 11</label><caption><p>Flavonoids present in apple.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g011.jpg"/></fig><fig position="float" id="molecules-30-01676-f012" orientation="portrait"><label>Figure 12</label><caption><p>The elagitannins punicalin and punicalagin, specific to pomegranates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g012.jpg"/></fig><fig position="float" id="molecules-30-01676-f013" orientation="portrait"><label>Figure 13</label><caption><p>Structures present in cranberry.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g013.jpg"/></fig><fig position="float" id="molecules-30-01676-f014" orientation="portrait"><label>Figure 14</label><caption><p>Anthocyanin derivatives present in greater quantities in blueberries.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-01676-g014.jpg"/></fig><table-wrap position="float" id="molecules-30-01676-t001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-01676-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of fruit CYP and drug transporter inhibitions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fruit </th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Interactions</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Types of Constituents and Examples</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results in Terms of Drug Interactions</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Grapefruit<break/>(<italic toggle="yes">Citrus &#215; paradise</italic>)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Rutaceae</italic>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Irreversible inhibition of CYP3A4.<break/>Inhibition of P-gp.</td><td align="left" valign="middle" rowspan="1" colspan="1">Furanocoumarins:<break/>Psoralen; Bergaptol; Bergapten;<break/>Bergamottin; Epoxybergamottin;<break/>6&#8242;,7&#8242;-dihydroxybergamottin;<break/>Oxypeucedanin.</td><td align="left" valign="middle" rowspan="1" colspan="1">Reduced absorption; decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OATP and P-gp inhibitions.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoids:<break/>Narirutin; Hesperidin; Rutin;<break/>Narengenin; Naringin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Orange <break/>(<italic toggle="yes">Valencia</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Rutaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incomplete inhibition of OATP1A2.<break/>Inhibition of OATP2B1.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No furanocoumarins.<break/>Flavonoids:<break/>Narirutin; Hesperidin;<break/>Phenolic acids:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No furanocoumarins.<break/>Fewer interactions generated.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seville orange<break/>(<italic toggle="yes">Citrus aurantium</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Rutaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4, CYP 2C9, and OATP inhibitions.<break/>P-gp not affected.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furanocoumarins: Bergapten.<break/>Flavonoids: Narirutin; Naringin.<break/>Phenolic acids:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid<break/>Caffeic acid; Chlorogenic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lime<break/>(<italic toggle="yes">Citrus aurantiifolia</italic>,<break/><italic toggle="yes">Citrus latifolia</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Rutaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4, CYP2C9, and OATP2B1 inhibitions.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Same Furanocoumarins, flavonoids, and polyphenols as in grapefruits.<break/>Bergapten; Bergamottin;<break/>Oxypeucedanin; Narirutin;<break/>Naringin; Naringenin; Hesperetin;<break/>Rutin; Eriocitrin; Isonaringenin;<break/>Vicenin; Lucenin; <italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid; Caffeic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced absorption; decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pomelo<break/>(<italic toggle="yes">Citrus grandis</italic> L. <italic toggle="yes">Osbeck</italic> or <italic toggle="yes">Citrus maxima</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Rutaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of CYP2C9, CYP3A4, and OATP2B1.<break/>P-gp not affected.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coumarins:<break/>Rutin; Meranzin; Taddanone<break/>Flavonoids:<break/>Naringin; Hesperidin; Apigenin<break/>Tangeretin; Nobiletin; Taddanone<break/>Naringin; Epicatechin.<break/>Phenolic acids:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid;<break/>Caffeic acid.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced absorption; decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fig<break/>(<italic toggle="yes">Ficus carica</italic> L.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Moraceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4 inhibition.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furanocoumarins <break/>Psoralen; Bergapten; Marmesin;<break/>Xanthotoxol; Xanthotoxin; Rutaretin; Angelicin; Pimpinellin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interactions have been reported with anticoagulant and antibacterial treatments.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blackberry<break/>(<italic toggle="yes">Morus alba</italic>, <italic toggle="yes">Morus nigra</italic>, <italic toggle="yes">Morus rubra</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Moraceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4, CYP3A1, and OATP-B1 inhibitions.<break/>P-gp and CYP3A4 modulations.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coumarins:<break/>Rutin.<break/>Flavonoids: <break/>Phloridzin; Quercetin;<break/>Kaempferol; Resveratrol.<break/>Phenolic acids:<break/>Chlorogenic acid.<break/>Anthocyanins.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased bioavailability.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apple <break/>(<italic toggle="yes">Malus domestica</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Rosaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PMAT/SLC29A4, CYP1A1, CYP2C9, OATP2B1, OATP1, and OATP3 inhibtions.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoids and polyphenols:<break/>Phloridzin; Phloretin; Hesperidin;<break/>Quercetin; Rutin.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potential reduction in absorption.<break/>No effect on CYP3A.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pomegranate<break/>(<italic toggle="yes">Punica granatum</italic> L.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Lythraceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4 and CYP2C9 inhibitions in vitro.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoids:<break/>Catechins; Epicatechins; Quercetin.<break/>Phenolic acids:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid;<break/>Caffeic acid; Chlorogenic acid.<break/>Proanthocyanidins.<break/>Eligatannins:<break/>Punicalin; Punicalagins.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioavailability unaffected in vivo.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cranberry<break/>(<italic toggle="yes">Vaccinium macrocarpon</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Ericaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A4, CYP1A2, and CYP2C9 inhibitions in vitro.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonols:<break/>Catechins; Epicatechin;<break/>Epigallocatechin; Quercetin;<break/>Kaempferol; Myricetin.<break/>Phenolic acids:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acid;<break/>Caffeic acid; Chlorogenic acid.<break/>Proanthocyanidins:<break/>Procyanidin A2; Procyanidin B2.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioavailability unaffected in vivo.</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blueberry<break/>(<italic toggle="yes">Vaccinium angustifolium</italic> Aiton and <italic toggle="yes">Vaccinium corymbosum</italic> L.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Ericaceae</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CYP3A inhibition in vitro.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonols:<break/>Catechins; Epicatechin;<break/>Epigallocatechin; Quercetin;<break/>Kaempferol.<break/>Phenolic acid:<break/><italic toggle="yes">p</italic>-Coumaric acid; Ferulic acidl<break/>Caffeic acid; Chlorogenic acid.<break/>Proanthocyanidins:<break/>Malvidin 3-glucoside;<break/>Malvidin 3-galactoside.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioavailability unaffected in vivo.</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>